Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Spain
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Authors: Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publications: 
IPVC, Barcelona, Spain, 23-27 March 2020
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Portugal, Spain
Condition Year Language Analysis type
, Infectious disease, Oncology 2020 English , Burden of illness, Observational study, Retrospective Field Study
 
 
Clinical management of serious infections attributable to carbapenem-resistant Gram-negative pathogens in Spanish hospitals
Authors: Ferrer R1, Calvo-Montes J2, Maseda E3, Salavert M4, Bou G5, Díaz-Regañón J6, López D6, Lozano V6, Gómez-Ulloa D7, Fenoll R7, Sánchez E7, McCann E8
Affiliations: 1 Vall d'Hebron University Hospital, Barcelona, Spain 2 Marqués de Valdecilla University Hospital, Santander, Spain 3 La Paz University Hospital, Madrid, Spain 4 La Fe University and Polytechnic Hospital, Valencia, Spain 5 La Coruña University Hospital, La Coruña, Spain, Spain 6 Merck Sharp & Dohme Corp., Madrid, Spain 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publications: 
ECCMID, Paris, France, 18-21 April 2020
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Infectious disease 2020 English , Observational study, Retrospective Field Study
 
 
Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Authors: Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17
Affiliations: 1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publications: 
ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece, Italy, Spain
Condition Year Language Analysis type
, Infectious disease 2020 English , Observational study, Retrospective Field Study
 
 
Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Authors: Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17
Affiliations: 1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publications: 
ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece, Italy, Spain
Condition Year Language Analysis type
, Infectious disease 2020 English , Observational study, Retrospective Field Study
 
 
Predictors of iron‑deficiency anemia in primary care older adults: a real‑world European multi‑country longitudinal study
Authors: Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F
Affiliations: Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico “A. Gemelli”, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy
Publications: 
Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6
Condition Year Language Analysis type
, Hematology 2020 English , Epidemiological study, Retrospective database analysis
 
 
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries
Authors: Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2)
Affiliations: 1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan
Publications: 
ISPOR 2020 Conference
Document Types: , Abstract
Countries: , Australia, Canada, France, Germany, Italy, Japan, Spain, UK
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019
Condition Year Language Analysis type
2020 English
 
 
Real-world treatment patterns of patients diagnosed with complicated urinary tract infections, complicated intra-abdominal infections, and hospital acquired and ventilator-associated bacterial pneumonia attributable to carbapenem-resistant Gram-negative bacilli in Spain
Authors: Ferrer R1, Fariñas MC2, Bou Arevalo G3, Maseda E4, Salavert M5, Gómez Ulloa D6, Fenoll R6, Sánchez E6, Doshi I7, Diaz-Regañon J8, Mccann E7
Affiliations: 1 Hospital Universitari Vall d’Hebron, Barcelona, Spain 2 Hospital Marqués de Valdecilla, Santander, Spain 3 Hospital Universitario A Coruña, La Coruña, Spain 4 Hospital Universitario La Paz, Madrid, Spain 5 Hospital Universitario y Politécnico La Fe, Valencia, Spain 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US 8 Merck Sharp & Dohme Corp., Madrid, Spain
Publications: 
ECCMID, Amsterdam, Netherlands, 13-16 April 2019
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Infectious disease 2019 English , Observational study, Retrospective database analysis
 
 
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up
Authors: Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7
Affiliations: 1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain
Publications: 
Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30704919
Condition Year Language Analysis type
, Rheumatology 2019 Spanish , Population Based Study, Survey research
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Authors: Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations: 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publications: 
Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Types: , Article
Countries: , Belgium, France, Poland, Portugal, Spain, Switzerland, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2019 English , Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study
 
 
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY
Authors: Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9
Affiliations: 1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US
Publications: 
EUROGIN, Monaco, France, 4-7 December 2019
Document Types: , Oral presentation
Countries: , China, France, Germany, Italy, Japan, Spain, UK, USA
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf
Condition Year Language Analysis type
, Clinical practice, Infectious disease, Methodology 2019 English , Epidemiological study, Observational study, Population Based Study
 
 
Patrones de tratamiento biológico en pacientes con enfermedades articulares inflamatorias. Estudio retrospectivo de 4 años de seguimiento
Authors: Juan D. Cañete1, Antonio Naranjo2, Javier Calvo3, Carmen Ordás4, Belén Aragón5, Gonzalo Nocea5, Montse Roset6, Antonio Fernández-Nebro7
Affiliations: 1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, España 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, España 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, España 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, España 6 Departamento de Health Economics and Outcomes Research, IQVIA, Barcelona, España 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, España
Publications: 
Reumatología Clínica, 2019. DOI: 10.1016
Document Types: , Article
Countries: , Spain
Abstract: http://reumatologiaclinica.org/es-patrones-tratamiento-biologico-pacientes-con-avance-S1699258X18302596
Condition Year Language Analysis type
, Drug Utlization Study 2019 Spanish , Clinical setting: hospital, Observational study
 
 
Impact of Stable Angina on health status and quality of life perception of currently treated patients. The BRIDGE 2 survey
Authors: Manolis AJ, Ambrosio G, Collins P, Dechend F, Lopez-Sendon J, Pegoraro V, Camm AJ
Affiliations: Manolis AJ: Department of Cardiology, Asklepeion General Hospital, Athens, Greece. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy.
Publications: 
Eur J Intern Med. 2019 Dec;70:60-67. doi: 10.1016/j.ejim.2019.09.013
Document Types: , Article
Countries: , Germany, Italy, Spain, UK
Abstract: https://www.sciencedirect.com/science/article/pii/S0953620519303267?via%3Dihub
Condition Year Language Analysis type
, Cardiovascular disease 2019 English , Quality of life, Survey research
 
 
Cost-utility model for 2nd generation treatment of chronic HCV in general population: impact of EASL recommendations in 2016 and 2018
Authors: Natlia Pascual-Argent (1,2); Carlos Crespo (1,3); Laura Planellas (4); Mriam Solozabal (4), Nria Perulero (4); Jaume Puig-Junoy (1,2)
Affiliations: (1) UPF Barcelona School of Management; (2) Dept. Economa y Empresa CRES UPF; (3) Universitat de Barcelona; (4) HEOR-RWE, IQVIA Spain
Publications: 
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Infectious disease 2019 Spanish , Clinical setting: hospital, Cost effectiveness
 
 
USO DE DATOS DE PRACTICA REAL PARA ANALIZAR LOS TRATAMIENTOS PRESCRITOS EN LA DIABETES TIPO 2 EN ESPA?A
Authors: Maria Targhetta*, Jean Paul Tang*, Hector Gutierrez*, Nuria Perulero*, Daniel Callejo*, Miriam Solozabal*
Affiliations: IQVIA Spain
Publications: 
XXXIX Jornadas de Economa de la Salud. Albacete, 12 al 14 de junio de 2019
Document Types: , Oral presentation
Countries: , Spain
Abstract: http://www.aes.es/jornadas/pdfs/Jornadas_AES_2019-Libro_abstracts.pdf
Condition Year Language Analysis type
, Diabetes 2019 Spanish , Clinical setting: Primary care, Population Based Study, Retrospective database analysis
 
 
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Authors: Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U
Affiliations: Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC
Publications: 
Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3
Document Types: , Article
Countries: , Belgium, France, Germany, Spain, UK
Abstract: https://link.springer.com/article/10.1007/s40261-019-00831-3
Condition Year Language Analysis type
, Drug safety, Drug Utlization Study 2019 English , Population Based Study, Retrospective database analysis
 
 
European Multi-Country Drug Utilization Study of Dulaglutide
Authors: Ayad K. Ali1, Karen E. Wells2, Mathieu Ros3, Massoud Toussi3
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France
Publications: 
ICPE, Philadelphia, USA, 24-28 August 2019
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden, UK
Condition Year Language Analysis type
, Diabetes, Drug safety 2019 English , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis
 
 
European survey on stable angina: real world insights on patients' characteristics, perception of disease, and quality of life
Authors: Heiman F1, Peduto I1, Pegoraro V1, Cipelli R1, Ambrosio G2, Camm AJ3, Collins P4, Dechend R5, Lopez-Sendon J6, Manolis AJ7
Affiliations: 1 IQVIA, Milan, Italy 2 Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy 3 Imperial College London, London, United Kingdom - Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. Georges University of London, London, United Kingdom 4 National Heart and Lung Institute, Imperial College London, United Kingdom - Royal Brompton Hospital, London, United Kingdom 5 Experimental and Clinical Research Center, A joint cooperation between the Max-Delbruck Center for Molecular Medicine and the Charit Medical Faculty, Berlin, Germany - HELIOS-Clinic, Berlin, Germany 6 Cardiology, Hospital Universitario La Paz, IdiPaz, Madrid, Spain 7 Department of Cardiology, Asklepeion General Hospital, Athens, Greece
Publications: 
ISPOR 22nd Annual European Congress, 2-6 November 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Cardiovascular disease 2019 English , Survey research
 
 
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries
Authors: Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2
Affiliations: 1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy
Publications: 
Annals of Hematology (2019) 98:15731582
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Condition Year Language Analysis type
, Hematology 2019 English , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis
 
 
Adoption of immuno-oncology in NSCLC, a real-world study in EU5.
Authors: Alejandra Martinez De Pinillos,Isabel Ricote Lobera,Cristina Martinez,Caroline Anger,Filippo Guglielmetti,Roberto Jorge Bitton
Affiliations: IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina
Publications: 
Journal of Clinical Oncology201937:15_suppl,e20631-e20631
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631
Condition Year Language Analysis type
, Oncology 2019 English , Retrospective database analysis
 
 
EPIDEMIOLOGY OF ATTENTION DEFICIT HYPERACTIVITY DISORDERS IN SPAIN BASED ON REAL-WORLD DATA
Authors: Ramos-Quiroga JA (1), Targhetta M (2), Gasche D (2), Rubio M (2), Perulero N (3)
Affiliations: 1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain; 3IQVIA Information, Barcelona, Spain
Publications: 
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Patient Registries & Real-World Study Methods 2019 English , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis
 
 
Análisis de la implementación de los Informes de Posicionamiento Terapéutico en España
Authors: Míriam Solozabal, Laura Planellas, Elisabet Viayna, Neus Canal
Affiliations: Health Economics & Outcomes Research. Real-World Insights. IQVIA España
Publications: 
Revista Española de Economía de la Salud. 2019; 14(3):596-605
Document Types: , Article
Countries: , Spain
Abstract: https://www.economiadelasalud.com/Articulo.aspx?i=v14n3d018
Condition Year Language Analysis type
, Health policy, Pricing and reimbursement, Public Health 2019 Spanish , Clinical setting: hospital, Clinical setting: Primary care, Internet or Interactive voice response system, Pricing & Reimbursement, Public Health
 
 
A REAL-WORLD DATA STUDY TO ANALYSE THE PHARMACOLOGICAL TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN SPAIN
Authors: Ramos-Quiroga JA (1), Tang JP (2), Solozabal M (2), De Prado A (2), Miñarro C (2), Callejo-Velasco D (2)
Affiliations: 1Hospital Universitari Vall d’Hebron, Barcelona, Spain, 2IQVIA Information, Madrid, Spain
Publications: 
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Patient Registries & Real-World Study Methods 2019 English , Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis
 
 
EMPAGLIFLOZIN VS SITAGLITPIN, SAXAGLIPTIN AND LIRAGLUTIDE IN SPAIN. A BUDGET IMPACT MODEL BASED ON THE CORE DIABETES MODEL AND CARDIOVASCULAR OUTCOMES TRIALS
Authors: Carrasco Perez M, Ustyugova A, Rubio M, Callejo-Velasco D, Gasche D, Gonzalez-Rojas Guix N
Affiliations: Boehringer Ingelheim and IQVIA
Publications: 
ISPOR Europe, Copenhagen, Denmark, 2-6 November 2019
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2019 English , Budget impact, Clinical setting: Primary care
 
 
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain.
Authors: Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W.
Affiliations: IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK.
Publications: 
Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403
Document Types: , Article
Countries: , Spain
Abstract: https://www.dovepress.com/cost-effectiveness-analysis-of-baricitinib-versus-adalimumab-for-the-t-peer-reviewed-fulltext-article-CEOR
Condition Year Language Analysis type
, Rheumatology 2019 English , Retrospective cohort analysis
 
 
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Authors: Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations: IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publications: 
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Types: , Poster
Countries: , Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019
Condition Year Language Analysis type
, Hematology, Oncology 2019 English , Public Health, Survey research
 
 
Initial Management of localised prostate cancer in the Elderly: An International Data Review
Authors: Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: 
SIOG 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: 
JCO ( ASCO 2018)
Document Types: , Abstract
Countries: , Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Drug treatment in melanoma: a real-world analysis across Europe and Japan
Authors: Martinez de Pinillos, Anger C, Nasuti P
Affiliations: IQVIA London UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Treatment algorithm for multiple myeloma: real-world insights across five European countries
Authors: Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2
Affiliations: 1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries
Authors: Hoyer L, Schmidt N
Affiliations: IQVIA Frankfurt Germany
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD)
Authors:  Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3
Affiliations: IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data
Authors:  Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3
Affiliations: 1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4)
Authors:  Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2
Affiliations: 1IQVIA Milan Italy , 2IQVIA London UK
Publications: 
CTOS 2018 Rome
Document Types: , Poster
Countries: , France, Germany, Italy, Spain
Condition Year Language Analysis type
, Oncology 2018 English
 
 
DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE
Authors:  Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2
Affiliations: 1 IQVIA London UK , 2IQVIA Madrid Spain
Publications: 
ISPOR Europe 2018
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe.
Authors: Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5
Affiliations: 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France
Publications: 
European Society of Cardiology (ESC) Congress, 2018, Munich, Germany
Document Types: , Poster
Countries: , Belgium, France, Poland, Portugal, Spain, Switzerland, UK
Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2018 English , Burden of illness, Cost of illness
 
 
EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
Authors: Bodaghi Charles, Benque Emma, Troubat Arnaud
Affiliations: IQVIA France - RWI
Publications: 
ISPOR 2018
Document Types: , Poster
Countries: , France, Germany, Spain, UK
Condition Year Language Analysis type
, Diabetes 2018 English , Clinical setting: Home care, Pricing & Reimbursement
 
 
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ‘TOL-AR-18 Questionnaire
Authors: Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R
Affiliations: Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain
Publications: 
Reumatología Clínica 2018; Sep 5. [Epub ahead of print]
Document Types: , Article
Countries: , Spain
Abstract: http://www.reumatologiaclinica.org/en/assessing-treatment-tolerability-for-rheumatoid/avance-resumen/S1699258X18301232/
Condition Year Language Analysis type
, Health status & patient reported outcomes, Rheumatology 2018 English , Clinical setting: hospital, Observational study
 
 
A real-world data study regarding hospital resources use and costs associated with melanoma cancer in Spain
Authors: Carmen Barrull, Ángel Baltasar, Daniel Callejo, Vanessa Gómez, Neus Canal, Miriam Solozabal
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-melanoma-cancer-in.pdf?la=en&hash=8C1394471FDDA3956BBF8788628C6443F1E3D5B6
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
A real-world data study regarding hospital resources use and costs associated with colorectal cancer in Spain
Authors: Laura Planellas, Míriam Solozabal, Carmen Barrull, Anna de Prado, Neus Canal, Vanessa Gómez
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-colorectal-cancer.pdf?la=en&hash=FE374C80DDC224B135913C13D65857DAE36D0007
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review
Authors: Jaume Puig-Junoya,b,c, Natàlia Pascual-Argenteb,c, Lluc Puig-Codinab, Laura Planellasd, Míriam Solozabald
Affiliations: aDepartment of Economics and Business (UPF), Pompeu Fabra University, Barcelona, Spain; bUPF Barcelona School of Management, Pompeu Fabra University, Barcelona, Spain; cUPF Center for Research in Health and Economics (CRES-UPF), Pompeu Fabra University, Barcelona, Spain; dHEOR-RWI, IQVIA Spain
Publications: 
Expert Review of Gastroenterology and Hepatology. Volume 12, 2018 - Issue 12
Document Types: , Article
Countries: , Spain
Abstract: https://www.tandfonline.com/doi/abs/10.1080/17474124.2018.1540929?journalCode=ierh20
Condition Year Language Analysis type
, Health economics, Infectious disease 2018 English , Clinical setting: hospital, Literature Review, Review
 
 
Hospital resources use and costs associated with 6 prevalent cancer in Spain, a Real World Data study
Authors: Daniel Callejo , Laura Planellas, Míriam Solozabal, Carmen Barrull, Neus Canal, Anna de Prado
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe, Barcelona, Spain, 10-14 November 2018
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/hospital-resources-use-and-costs-associated-with-6-prevalent-cancers-in-spain-a-real-world-data-stud.pdf?la=en&hash=C28017910D9722573D7A318AB3782530D5F50054
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
A real-world data study regarding hospital resources use and costs associated with breast cancer in Spain
Authors: Daniel Callejo , Vanessa Gómez, Míriam Solozabal, Laura Planellas, Ágata Carreño, Ángel Baltasar
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe, Barcelona, Spain, 10-14 November 2018
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-breast-cancer-in-s.pdf?la=en&hash=8547AD20386AF0B3E1DA95EDA710A7EEF6E40C68
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
A real-world data study regarding hospital resources use and costs associated with bladder cancer in Spain
Authors: Anna de Prado, Ángel Baltasar, Vanessa Gómez, Carme Barrull, Àgata Carreño, Laura Planellas
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-bladder-cancer-in.pdf?la=en&hash=9A2EA74E7E8AEC14E41A2D6DACD80911C716853F
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
A real-world data study regarding hospital resources use and costs associated with lung cancer in Spain
Authors: Anna de Prado, Daniel Callejo, Vanessa Gómez, Angel Baltasar, Neus Canal, Carme Barrull
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-lung-cancer-in-spa.pdf?la=en&hash=8F884E874C670E07BCA72315DC3B6E042F558F23
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
How a new innovation assessment tool relates to recent drug launches for Spanish National acess
Authors: Míriam Solozabal, Elisabet Viayna, Marta Rubio, Mireia Sumalla, Ane Otermin, David Gasche, Laura Planellas, Daniel Callejo
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-13/how-a-new-innovation-assessment-tool-relates-to-recent-drug-launches-for-spanish-national-access.pdf?la=en&hash=1D16D1D70ADE257D3A09480F1B1EEB002BDE83A4
Condition Year Language Analysis type
, Pricing and reimbursement 2018 English , Clinical setting: hospital, Pricing & Reimbursement
 
 
A real-world data study regarding hospital resources use and costs associated with prostate cancer in Spain
Authors: Míriam Solozabal, Anna de Prado, Laura Planellas, Ángel Baltasar, Àgata Carreño, Daniel Callejo
Affiliations: HEOR-RWI, IQVIA Spain
Publications: 
ISPOR Europe 2018. 10-14 November 2018 | Barcelona, Spain
Document Types: , Poster
Countries: , Spain
Abstract: https://www.iqvia.com/-/media/iqvia/pdfs/isporbarcelona2018posters/november-14/a-realworld-data-study-regarding-hospital-resources-use-and-costs-associated-with-prostate-cancer-in.pdf?la=en&hash=1DA52D1BC0EDBFCE32B1DB5C46308CE4E06D318F
Condition Year Language Analysis type
, Oncology 2018 English , Clinical setting: hospital, Cost analysis, Retrospective database analysis
 
 
Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain
Authors: Soler-Cataluña JJ1, Fernández Villar A2, Piñera Salmerón PL3, Román-Rodríguez M4, Huerta Hernández A5, Roset Gamisans M6
Affiliations: 1 Servicio de Neumología, Hospital de Arnau de Vilanova-Lliria, Valencia, España. 2 Servicio de Neumología, Hospital Álvaro Cunqueiro. Instituto de Investigación Biomédica Galicia Sur, Vigo (Pontevedra), España. 3 Servicio de Urgencias, Hospital General Universitario Reina Sofía, Murcia, España. 4 Médico de familia, Centro de Salud Son Pisà, Islas Baleares, Mallorca, España. 5 Departamento de Evaluación de Medicamentos, GlaxoSmithKline, Tres Cantos, Madrid, España. 6 Health Economics and Outcomes Research, IQVIA, Barcelona, España.
Publications: 
Semergen. 2018 Oct;44(7):449-457
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30206038
Condition Year Language Analysis type
, Clinical practice 2018 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Observational study
 
 
Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study
Authors: Ali AK, Toussi M, Phillips S, Roste M
Affiliations: Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA
Publications: 
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Document Types: , Abstract
Countries: , France, Germany, Spain, Sweden
Condition Year Language Analysis type
, Diabetes, Drug Utlization Study, Drug Utlization Study 2018 English , Database Study, Epidemiological study
 
 
Validation of the Spanish version of the Bladder Pain/Interstitial Cystitis-Symptom Score (BPIC-SS) questionnaire. A useful tool for the diagnosis of bladder pain syndrome
Authors: S. Arlandis, A. Franco, A.M. Mora, P. Rebollo
Affiliations: Hospital Universitario y Politcnico La Fe, Valencia, Spain Hospital Universitario Clnic, Barcelona, Spain Departamento Mdico, Astellas Pharma S.A., Madrid, Spain Health Economics & Outcomes Research, Real-World Evidence Solutions, QuintilesIMS, Barcelona, Spain
Publications: 
Actas Urol Esp. 2018;42(7):457-464
Document Types: , Article
Countries: , Spain
Abstract: https://www.elsevier.es/en-revista-actas-urologicas-espanolas-english-392-articulo-validation-spanish-version-bladder-pain-interstitial-S2173578618300933
Condition Year Language Analysis type
, Urology, Womens Health 2018 English , clinical setting: Secondary care, Epidemiological study, Observational study
 
 
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.
Authors: López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4.
Affiliations: 1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Publications: 
Infect Agent Cancer. 2018 May 2;13:15.
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937
Condition Year Language Analysis type
, Health economics, Immunology and Vaccination, Infectious disease, Oncology 2018 English , Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research
 
 
Valoración de la innovación, ¿es “el innovómetro” una herramienta útil y su clasificación reproducible?
Authors: Otermin A, Callejo D, Gasche D, Viayna E, Rubio M, Sumalla M, Solozabal M.
Affiliations: HEOR-RWI, IQVIA
Publications: 
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/
Condition Year Language Analysis type
, Health policy, Pricing and reimbursement 2018 Spanish , Pricing & Reimbursement
 
 
Análisis coste-utilidad de antivirales de acción directa de segunda generación para la hepatitis C: Una revisión sistemática.
Authors: Puig-Junoy J123, Pascual-Argente N23, Puig-Codina L2, Planellas L4, Solozabal M4.
Affiliations: 1Pompeu Fabra University (UPF), Department of Economics and Business; 2UPF Barcelona School of Management; 3Center for Research in Health and Economics (CRES-UPF); 4IQVIA, Real-World Insights, Barcelona
Publications: 
XXXVIII Jornadas de Economía de la Salud, Gran Canaria 2018
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/
Condition Year Language Analysis type
, Health economics, Infectious disease 2018 Spanish , Clinical setting: hospital, Literature Review, Review, Survey research
 
 
Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23)
Authors: Martínez-Ginés ML, García-Domínguez JM, Forero L, Canal N, Rebollo P, Prefasi D, Honan CA, Maurino J.
Affiliations: Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid, SpainDepartment of Neurology, Hospital Universitario Puerta del Mar, Cádiz, Spain IQVIA, Barcelona, Spain Medical Department, Roche Farma, Madrid, Spain Department of Psychology, School of Medicine, University of Tasmania, Newnham, Australia
Publications: 
Mult Scler Relat Disord. 2018 May;22:115-119
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29656271
Condition Year Language Analysis type
, Neurological disorders 2018 English , Burden of illness, Clinical setting: hospital, Patient questionnaire
 
 
Real World Data y Real World Evidence como fuentes de evidencia en oncología. Estado actual y perspectivas de futuro
Authors: Daniel Callejo y Anna de Prado
Affiliations: IQVIA Spain
Publications: 
New Medical Economics nº 79;22-24
Document Types: , Article
Countries: , Spain
Abstract: https://issuu.com/raizpublicidad/docs/nme_num79/22
Condition Year Language Analysis type
, Oncology 2018 Spanish , Clinical setting: hospital, Review
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Authors: Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publications: 
Document Types: 
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085
Condition Year Language Analysis type
2018 English
 
 
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Authors: Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations: 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Authors:  Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations: 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publications: 
ESMO 2018
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, South Korea, Spain, UK
Abstract: ESMO 2018 Congress
Condition Year Language Analysis type
, Oncology 2018 English
 
 
Real World analysis for immune related side effects in 3000 patients
Authors: Mitrofan L 1, Moehler T 2, Ruiz M 3
Affiliations: 1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain
Publications: 
ESMO - ImmunoOncology
Document Types: , Poster
Countries: , Europe, France, Germany, Spain, UK
Condition Year Language Analysis type
, Oncology 2017 English
 
 
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
Authors: Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6.
Affiliations: Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom.
Publications: 
Breast. 2017 Apr;32:247-255.
Document Types: , Article
Countries: , France, Germany, Italy, Spain
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648
Condition Year Language Analysis type
, Oncology 2017 English , clinical setting: Secondary care, Retrospective database analysis
 
 
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
Authors: Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7
Affiliations: 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany
Publications: 
JHEOR 2017;5(1):89-108
Document Types: , Article
Countries: , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK
Condition Year Language Analysis type
, Immunology and Vaccination, Infectious disease, Respiratory disease 2017 English , Epidemiological study, Public Health
 
 
Spanish cultural adaptation of the short version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23)
Authors: Martínez-Ginés ML, García-Domínguez JM, Sarmiento M, Maurino J
Affiliations: Martínez-Ginés ML: Servicio de Neurología, Hospital Universitario Gregorio Marañón, Madrid, España Sarmiento M: QuintilesIMS, Barcelona, España
Publications: 
Neurología 2017; Apr 5 [Epub ahead of print]
Document Types: , Letter
Countries: , Spain
Abstract: http://www.elsevier.es/es-revista-neurologia-295-avance-resumen-adaptacion-cultural-al-espanol-del-S0213485317301056
Condition Year Language Analysis type
, Health status & patient reported outcomes, Neurological disorders 2017 Spanish , Patient questionnaire
 
 
Impact of locally advanced or metastatic prostate cancer on the quality of life
Authors: López-Calderero I, López-Fando L, Ríos-González E, Maisonobe P, Hernández-Yuste E, Sarmiento-Jordán M
Affiliations: López-Calderero I: Hospital Can Misses, Ibiza, España Sarmiento M: QuintilesIMS, Barcelona, España
Publications: 
Actas Urológicas Españolas 2017;41(6):368-75
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28256271
Condition Year Language Analysis type
, Oncology, Urology 2017 English , Quality of life
 
 
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine.
Authors: López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4
Affiliations: 1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa
Document Types: , Poster
Countries: , Spain
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 English , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research
 
 
Análisis de coste-efectividad de empagliflozina en pacientes con diabetes mellitus tipo 2 y enfermedad cardiovascular establecida en España [Analysis of cost-effectiveness of empagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease established in Spain].
Authors: Barrull C1, Massafrets M2, Planellas L1, Perulero N1
Affiliations: 1 RWI, QuintilesIMS, Barcelona 2 Market Access Department, Boehringer Ingelheim, Barcelona
Publications: 
XXXVII Jornadas de Economía de la Salud2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Cardiovascular disease, Diabetes, Health economics, Pricing and reimbursement 2017 Spanish , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Cost effectiveness, Cost utility, Literature Review, Patient questionnaire, Randomised controlled trial
 
 
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine].
Authors: López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4
Affiliations: 1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research
 
 
Characteristics, resource utilization and safety profile of patients prescribed with neuropathic pain treatments: a real-world evidence study on general practices in Europe.
Authors: Katz P1, Pegoraro V2, Liedgens H1.
Affiliations: 1 Grunenthal GmbH , Aachen , Germany. 2 QuintilesIMS, Milan, Italy.
Publications: 
Current Medical Research and Opinion
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28537441
Condition Year Language Analysis type
, Pain 2017 English , Database Study, Epidemiological study, Longitudinal study, Observational study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis
 
 
Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review].
Authors: Lopez N1, Viayna E2, Perulero N2, San-Martin M1
Affiliations: 1 Sanofi Pasteur-MSD 2 Quintiles IMS
Publications: 
Vacunas. 2017;18(2):36-42
Document Types: , Article
Countries: , Spain
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review
 
 
Carga epidemiológica y económica de las patologías asociadas al virus del papiloma humano en españa: revisión de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review].
Authors: Lopez N1, Viayna E2, Perulero N2, San-Martin M1
Affiliations: 1 Sanofi Pasteur-MSD 2 Quintiles IMS
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Dermatology, Health economics, Immunology and Vaccination, Oncology 2017 Spanish , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review
 
 
Análisis de las diferencias en el tiempo de elaboración de los informes de posicionamiento terapéutico [Analysis of the differences in the time of elaboration of the reports of therapeutic positioning].
Authors: Viayna E, Planellas L, Solozabal M
Affiliations: Quintiles IMS
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Oral presentation
Countries: , Spain
Abstract: http://www.aes.es/jornadas/en/
Condition Year Language Analysis type
, Health policy 2017 Spanish , Literature Review, Public Health
 
 
Comparison of incremental cost-utility ratios and sales of direct oral anticoagulants across EU-5 countries.
Authors: Viayna E, Planellas L
Affiliations: Quintiles IMS
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/Event/index/2017Glasgow
Condition Year Language Analysis type
, Cardiovascular disease 2017 English , Cost utility, Literature Review
 
 
Revisión de modelos económicos de coste-efectividad/ coste-utilidad desarrollados con los nuevos agentes antivirales de acción directa para el tratamiento de pacientes con hepatitis c [Review of economic cost-effectiveness / cost-utility models developed with new direct-acting antiviral agents for the treatment of patients with hepatitis C].
Authors: Planellas L1, Pascual N2, Solozabal M1, Rebollo P1, Puig-Junoy J2
Affiliations: 1 QuintilesIMS, RWI, Barcelona, Spain 2 CRES - Universitat Pompeu Fabra, Barcelona, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/#comunicaciones
Condition Year Language Analysis type
, Health economics, Infectious disease 2017 Spanish , Cost effectiveness, Literature Review, Review
 
 
Modelización del comportamiento de fármacos biosimilares en 5 países de europa [Modeling of the behavior of biosimilar drugs in 5 European countries].
Authors: Manganelli AG1, Solozabal M2, Planellas L2, Rebollo P2, Puig-Junoy J1
Affiliations: 1 CRES - Universitat Pompeu Fabra, Barcelona, Spain 2 QuintilesIMS, RWI, Barcelona, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.aes.es/jornadas/es/#comunicaciones
Condition Year Language Analysis type
, Clinical practice, Drug Utlization Study 2017 Spanish , Clinical setting: hospital
 
 
Tiempos de Acceso Regional de Productos Hospitalarios [Regional Access Times for Hospital Products].
Authors: Solozabal M1, Fraile S2, Gómez V1
Affiliations: 1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Oral presentation
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/
Condition Year Language Analysis type
, Health policy 2017 Spanish , Clinical setting: hospital, Market impact, Retrospective database analysis
 
 
Relación entre los tiempos del proceso de P&F y el acceso regional de productos hospitalarios en España [Relationship between the times of the P & F process and the regional access of hospital products in Spain].
Authors: Gómez V1, Fraile S2, Solozabal M1
Affiliations: 1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain
Publications: 
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España
Document Types: , Oral presentation
Countries: , Spain
Abstract: http://www.aes.es/jornadas/es/
Condition Year Language Analysis type
, Health policy 2017 Spanish , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research
 
 
Evolution of the time-to-market of hospital products in Spain.
Authors: Gómez-Navarro V1, Fraile S2, Solozabal M1
Affiliations: 1 RWI, QuintilesIMS, Barcelona, Spain 2 Hospital Offering development, QuintilesIMS, Madrid, Spain
Publications: 
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom
Document Types: , Poster
Countries: , Spain
Abstract: https://www.ispor.org/Event/index/2017Glasgow
Condition Year Language Analysis type
, Health policy 2017 English , Clinical setting: hospital, Market impact, Retrospective database analysis, Survey research
 
 
Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story
Authors: Mpima S1, Moehler T2, Kanter S3, Mitrofan L4
Affiliations: 1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA
Publications: 
ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004
Condition Year Language Analysis type
, Oncology 2017 English , Retrospective database analysis
 
 
Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016.
Authors: Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3
Affiliations: 1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom
Publications: 
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2017 English , Retrospective database analysis
 
 
Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016.
Authors: Hoyer L, Schmidt N
Affiliations: QuintilesIMS Global Oncology, Central, East & South Europe
Publications: 
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2017 English , Retrospective database analysis
 
 
Perception of symptoms and quality of life –comparison of patients’ and physicians’ views in the COPD MIRROR study
Authors: Celli B1, Blasi F2, Gaga M3, Singh D4, Vogelmeier C5, Pegoraro V6, Caputo N7, Agusti A8.
Affiliations: 1 Pulmonary and Critical Care Medicine Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 2 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy 3 7th Respiratory Medicine Department and Asthma Centre, Athens Chest Hospital, Athens, Greece 4 Medicines Evaluation Unit, University of Manchester, University Hospital of South Manchester, Manchester, UK 5 Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany, German Center for Lung Research (DZL), Giessen, Germany 6 Real World Insight, QuintilesIMS, Milan, Italy 7 Primary Market Research, QuintilesIMS, Milan, Italy 8 Respiratory Institute, Hospital Clinic, IDIBAPS, CibeRes, University of Barcelona, Barcelona, Spain
Publications: 
International Journal of COPD
Document Types: , Article
Countries: , Germany, Italy, Spain
Abstract: https://www.dovepress.com/perception-of-symptoms-and-quality-of-life-comparison-of-patients-and--peer-reviewed-article-COPD
Condition Year Language Analysis type
, Respiratory disease 2017 English , Survey research
 
 
Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational study
Authors: Rafael Arroyo1, Angel P Sempere2, Elena Ruiz-Beato3, Daniel Prefasi4, Agata Carreo5, Montse Roset5, Jorge Maurino4
Affiliations: 1. Department of Neurology, Hospital Universitario Quirnsalud, Madrid, Spain 2. Department of Neurology, Hospital General Universitario de Alicante, Alicante, Spain 3. Health Economics and Outcomes Research Unit, Roche Farma SA, Madrid, Spain 4. Medical Department, Roche Farma SA, Madrid, Spain 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
BMJ Open. 2017 Mar 8;7(3):e014433.
Document Types: , Article
Countries: , Spain
Abstract: https://bmjopen.bmj.com/content/7/3/e014433
Condition Year Language Analysis type
, Neurological disorders 2017 English , clinical setting: Secondary care, Observational study
 
 
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES
Authors: M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. Díaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group
Affiliations: 1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway
Publications: 
EULAR, Madrid, 2017
Document Types: , Abstract
Countries: , Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland
Abstract: http://ard.bmj.com/content/76/Suppl_2/656.3
Condition Year Language Analysis type
, Rheumatology 2017 English , Epidemiological study
 
 
Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study
Authors: Mònica Monteagudo, Montse Roset, Teresa Rodriguez-Blanco, Laura Muñoz, Marc Miravitlles
Affiliations: 1. Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; 2. Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain; 3. IMS Health, Barcelona, Spain; 4. Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain; 5. Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
Publications: 
Int J Chron Obstruct Pulmon Dis. 2017 Apr 12;12:1145-1152
Document Types: , Abstract
Countries: , Spain
Abstract: 1 Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain; 2 Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Spain; 3 IMS Health, Barcelona, Spain; 4 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain; 5 Pneumology Department, Hospital Universitari Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
Condition Year Language Analysis type
, Respiratory disease 2017 English , Observational study
 
 
Healthcare resource utilization and cost among males with lower urinary tract symptoms with a predominant storage component in Spain: The epidemiological, cross-sectional MERCURY study
Authors: Errando-Smet C1, Müller-Arteaga C2, Hernández M3, Lenero E4, Roset M5.
Affiliations: 1. Department of Urology, Fundació Puigvert, Barcelona, Cartagena, Spain. 2. Department of Urology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. 3. Department of Medical Affairs, Astellas Pharma Europe B.V., Madrid, Spain. 4. Medical Affairs Global Development, Astellas Pharma, Northbrook, Illinois. 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain.
Publications: 
Neurourol Urodyn. 2018 Jan;37(1):307-315
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28464366
Condition Year Language Analysis type
, Urology 2017 English , Observational study
 
 
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings
Authors: Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H
Affiliations: Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France.
Publications: 
Rheumatology (Oxford). 2017 May 1;56(5):818-828
Document Types: , Article
Countries: , France, Germany, Italy, Spain, Sweden
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765
Condition Year Language Analysis type
, Immunology and Vaccination, Rheumatology 2017 English , Retrospective Field Study
 
 
A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
Authors: Gizzo S1, Garcia-Velasco JA2, Heiman F3, Ripellino C3, Bühler K4
Affiliations: 1 Department of Woman and Child Health, University of Padua, Padua, Italy 2 Department of Obstetrics and Gynecology, Rey Juan Carlos University Madrid, Madrid, Spain 3 IMS Health Information Solutions Italy Srl, Milan, Italy 4 Centre for Gynaecology, Endocrinology, and Reproductive Medicine, Ulm and Stuttgart, Germany
Publications: 
Int J Womens Health
Document Types: , Manuscript in preparation
Countries: , Germany, Italy, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153281/
Condition Year Language Analysis type
, Health economics, Pregnancy 2016 English , Cost effectiveness
 
 
Novel therapy options for advanced & metastatic melanoma patients in EU5 countries result in a changing treatment pattern especially in BRAF mutant patients.
Authors: Bernhardt M, Schmidt N, Mambrini T
Affiliations: IMS Health Global Oncology, Central, East & South Europe
Publications: 
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32626
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015.
Authors: Bernhardt M, Schmidt N, Mambrini T
Affiliations: IMS Health Global Oncology, Central, East & South Europe
Publications: 
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32287
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
Brain metastasis in NSCLC in the era of precision Medicine.
Authors: Mpima S, Anger C, Mitrofan L
Affiliations: 1 IMS Health, London, United Kingdom 2 IMS Health, La Defense, France
Publications: 
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Brain-metastases-in-NSCLC-patients-in-the-era-of-precision-medicine
Condition Year Language Analysis type
, Oncology 2016 English , Observational study
 
 
Characteristics, resources utilization and safety profile of patients with acute pain: a European real world evidence study.
Authors: Katz P1, Pegoraro V2, Heiman F, Liedgens H1.
Affiliations: 1 Grunenthal GmbH, Aachen, Germany 2 IMS Health Information Solutions Italy Srl, Milan, Italy.
Publications: 
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Types: , Poster
Countries: , Belgium, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Infectious disease, Neurological disorders, Pain 2016 Italian , Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis
 
 
17P Deletion and TP53 Gene Mutation (17P/TP53) testing behaviour and treatment patterns for Chronic Lymphocytic Leukaemia (CLL) patients in France, Germany, Italy, Spain and U.K. (EU5).
Authors: Bermudez F, Karanais Y, Mistry H, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: 
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32724
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES
Authors: Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2
Affiliations: 1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain
Publications: 
ISPOR 21st, May 2016 Washington, USA
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
Real Life Progression Free Survival and treatment Patterns for Patients with Metastatic Renal Cell Carcinoma treated with Targeted Therapies in France: Analysis of IMS RWD Oncology Cross-sectional Survey Data.
Authors: Maroun R, Mitrofan L, Benjamin L, Nachbaur G, Maunoury F, Le Jeunne P, Durand Zaleski I
Affiliations: GlaxosmithKline, Health Economics and Outcome Research, Marly le Roi France, Eceve, Paris, France, Quintiles IMS, France Le Mans, France, URC Eco, Paris, France
Publications: 
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN47.pdf
Condition Year Language Analysis type
, Oncology 2016 English , Longitudinal study
 
 
Understand the Role of dermatologists and Oncologists in the treatment of Melanoma in France and the UK.
Authors: Mpima S, Casey V, Nasuti P
Affiliations: QuintilesIMS, London, United Kingdom
Publications: 
IPSOR 2016 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)32943-6/pdf
Condition Year Language Analysis type
, Oncology 2016 English , Observational study
 
 
Use of Real World Data in identifying relevant comparators in medico economic models at EU5 level: A case study on Multiple Myeloma.
Authors: Jubert H, Karusisi N, Kolahi C, Mitrofan L
Affiliations: QuintilesIMS, La Defense, France
Publications: 
IPSOR 2016 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition Year Language Analysis type
, Oncology 2016 English
 
 
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe.
Authors: Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3
Affiliations: 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium
Publications: 
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria
Document Types: , Abstract
Countries: , Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK
Condition Year Language Analysis type
, Cardiovascular disease 2016 English
 
 
Epidemiology of iron deficiency anaemia in four European countries: a population-based study in primary care.
Authors: Levi M1-2, Rosselli M3, Simonetti M1, Brignoli O4, Cancian M4, Masotti A5, Pegoraro V6, Cataldo N6, Heiman F6, Chelo M1, Cricelli I1, Cricelli C4, Lapi F1.
Affiliations: 1 Health Search Italian College of General Practitioners and Primary Care, Florence 2 Department of Health Sciences, University of Florence, Florence, Italy 3 Institute for Liver and Digestive Health, Royal Free Hospital, University College of London, London, UK 4 Italian College of General Practitioners and Primary Care, Florence 5 Department of Transfusion Medicine, Local Health Authority n°5, Pordenone 6 IMS Health Information Solutions Medical Research srl, Milan, Italy
Publications: 
Eur J Haematol. 2016 May 7. doi: 10.1111/ejh.12776
Document Types: , Article
Countries: , Belgium, Germany, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/?term=Epidemiology+of+iron+deficiency+anaemia+in+four+European+countries%3A+a+population-based+study+in+primary+care.
Condition Year Language Analysis type
, Nutritional Disorders 2016 English , Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis
 
 
USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA
Authors: Jubert H, Kolahi C, Karusisi N, Mitrofan L
Affiliations: IMS Health France
Publications: 
19th ISPOR congress 2016
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf
Condition Year Language Analysis type
, Health economics, Oncology 2016 English , Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis
 
 
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Authors: Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations: 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publications: 
Clinical Epidemiology
Document Types: , Article
Countries: , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/
Condition Year Language Analysis type
, Oncology 2016 English , Literature Review
 
 
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
Authors: Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations: 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States
Publications: 
Dig Liver Dis. 2016 Jun;48(6):601-7.
Document Types: , Article
Countries: , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
Condition Year Language Analysis type
, Gastrointestinal disorders 2016 English , Burden of illness, Patient questionnaire, Survey research
 
 
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study
Authors: Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations: 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States.
Publications: 
Dig Liver Dis. 2016 Jun;48(6):592-600
Document Types: , Article
Countries: , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
Condition Year Language Analysis type
, Gastrointestinal disorders 2016 English , Burden of illness, Patient questionnaire
 
 
Coste del síndrome del intestino irritable con predominio de estreñimiento en España
Authors: Xavier Cortés1, Montse Roset2, Carmen Barrull2, Carolina Sais3, Anna Raya4
Affiliations:  1 Departamento Médico, Almirall S.A., Barcelona, España; 2 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 3 IASIST, Barcelona, España; 4 Departamento de Marketing, Almirall S.A., Barcelona, España
Publications: 
PharmacoEcon Span Res Artic (2016) 13(1):1-8.
Document Types: , Article
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007/s40277-015-0048-0
Condition Year Language Analysis type
, Clinical practice, Gastrointestinal disorders, Health economics 2016 Spanish , Burden of illness, Clinical setting: Primary care, Cost analysis, Retrospective database analysis
 
 
Impacto presupuestario del uso de un contraste isoosmolar frente a contrastes de baja osmolaridad en pacientes con alto riesgo de nefropatía inducida por contraste en el entorno hospitalario español
Authors: Eduardo Pinar1, José María Hernández2, Josepa Mauri3, Francisco Picó4, Rafael Ruiz5, Ángel Luis de Francisco6, Carmen Barrull7, Emilio Moreno8, Alexis Sampedro8, Felipe Hernández9
Affiliations: 1 Servicio de Hemodinámica, Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, España; 2 Unidad de Hemodinámica, Hospital Virgen de la Victoria, Málaga, España; 3 Unitat d’Hemodinàmica i Cardiologia Intervencionista, Hospital Universitari Germans Trias i Pujol, Barcelona, España; 4 Unidad de Cardiología y Hemodinámica, Hospital Quirón, Murcia, España; 5 Servicio de Hemodinámica e Intervención Endovascular, Hospital Virgen Macarena, Sevilla, España; 6 Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, España; 7 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 8 Departamento Médico, GE Healthcare, Madrid, España; 9 Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, España
Publications: 
PharmacoEcon Span Res Artic (2016) 13(1):17-24.
Document Types: , Article
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007%2Fs40277-015-0049-z
Condition Year Language Analysis type
, Cardiovascular disease, Drug safety, Drug Utlization Study, Health economics 2016 Spanish , Budget impact, Clinical setting: hospital
 
 
The Burden of Ulcerative Colitis and Crohn’s Disease in Spain
Authors: Cortés X1, Fernández-Salazar L2, Márquez L3, Ramos L4, Díaz Rubio C5, Planellas L6, Gasche D6
Affiliations: 1Gastroenterology Section, Internal Medicine of Hospital Universitario de Sagunto. University CEU Cardenal Herrera, Department of Medicine, Valencia; 2Department of Gastroenterology of Hospital Clínico Universitario de Valladolid; Department of Gastroenterology of Hospital del Mar de Barcelona; 4Department of Gastroenterology of Hospital Universitario de Canarias; 5Market Access Department, AbbVie; 6HEOR-RWE, IMS Health
Publications: 
Revista Española de la Economía de Salud (EDS). 2016;11(5):902-913
Document Types: , Article
Countries: , Spain
Abstract: http://www.economiadelasalud.com/Articulo.aspx?i=n5d018
Condition Year Language Analysis type
, Gastrointestinal disorders, Health economics, Immunology and Vaccination 2016 English , Burden of illness, Clinical setting: hospital, Survey research
 
 
Análisis del impacto presupuestario de misoprostol en la maduración cervical e inducción del parto a término
Authors: De la Torre A1, Arjona Berral JA1, Gasche D2, Miñarro C2
Affiliations: 1Unidad de Gestión Clínica de Obstetricia y Ginecología, Hospital Universitario Reina Sofía de Córdoba, Córdoba, España; 2Health Economics & Outcomes Research Real-World Evidence Solutions, IMS Health, S.A., Madrid, España
Publications: 
Pharmacoecon Span Res Artic (2016) 13:141–147
Document Types: 
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007/s40277-016-0060-z
Condition Year Language Analysis type
, Health economics 2016 Spanish , Budget impact, Clinical setting: hospital, Literature Review
 
 
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective
Authors: Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J7.
Affiliations: 1Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. Electronic address: Nicolai.Maass@uksh.de. 3Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr. 4Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. Electronic address: KBerger@de.imshealth.com. 5Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. Electronic address: FMacDougall@uk.imshealth.com. 6AstraZeneca, London, United Kingdom. Electronic address: jukka.montonen@astrazeneca.com. 7AstraZeneca, London, United Kingdom. Electronic address: Jan.Lewis@astrazeneca.com.
Publications: 
Breast. 2016 Dec 20. pii: S0960-9776(16)30264-8.
Document Types: , Article
Countries: , France, Germany, Italy, Spain
Abstract: https://linkinghub.elsevier.com/retrieve/pii/S0960-9776(16)30264-8
Condition Year Language Analysis type
, Oncology 2016 English , Retrospective database analysis
 
 
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.
Authors: Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14.
Affiliations: 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland.
Publications: 
Ann Rheum Dis. 2015 Jun;74(6):979-84
Document Types: , Article
Countries: , Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Rheumatology 2015 English , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles
 
 
Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed?
Authors: Charnock J, Bruce A, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: 
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e11581
Condition Year Language Analysis type
, Oncology 2015 English
 
 
Evolution of RAS testing in colorectal cancer, in France, Germany, Italy, Spain and UK (EU5).
Authors: Bruce A, Anger C, Gajeperia C
Affiliations: IMS Health, London, United Kingdom
Publications: 
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e14679
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
Standards of care for first-line HER2+ metastatic breast cancer (mBC): Russia vs. EU5 (France, Germany, Italy, Spain, and UK).
Authors: Bruce A, Hurlock J
Affiliations: IMS Health, London, United Kingdom
Publications: 
ESMO 2015 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29740
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
Stratification of high risk HER2-/HR+ patients following AI therapy.
Authors: Mitrofan L, Gajperia C, Charnock J, Anger C
Affiliations: IMS Health, London, United Kingdom
Publications: 
ESMO 2015 Annual Meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29751
Condition Year Language Analysis type
, Oncology 2015 English , Retrospective database analysis
 
 
ASSESSING THE COST-EFFECTIVENESS OF USING ACLIDINIUM BROMIDE 400 µG /FORMOTEROL FUMARATE DIHYDRATE 12 µG COMPARED TO ACLIDINIUM BROMIDE 400 µG IN THE MANAGEMENT OF MODERATE TO SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Authors: Ramos M1, Haughney J2, Henry N3, Lindner L4, Lamotte M1
Affiliations: 1IMS Health, Vilvoorde, Belgium, 2University of Aberdeen, Aberdeen, UK, 3IMS Health, London, UK, 4AstraZeneca, Barcelona, Spain
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Belgium, Spain, UK
Condition Year Language Analysis type
, Respiratory disease 2015 English , Cost analysis
 
 
AN ASSESMENT OF ENOXAPARINE BENEFIT ON HEALTHCARE BUDGET IN SPAIN
Authors: Delgado M1, Restovic G2, Planellas L2, Rubio M1, Miñarro C3
Affiliations: 1Sanofi, Barcelona, Spain, 2IMS Health, Barcelona, Spain, 3IMS Health, Madrid, Spain
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2015 English
 
 
MEDICAL COST OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (NVAF) AND TREATED WITH VITAMIN K ANTAGONISTS (VKAS) ACCORDING TO INR CONTROL STATUS IN SPAIN
Authors: Postema R1, Bardoulat I2, Roset M3, Maurel F4, Lefevre C5, Evans D5
Affiliations: 1Bristol-Myers Squibb, Braine-l'Alleud, Belgium, 2IMS Health, Paris, France, 3IMS Health, Barcelona, Spain, 4IMS Health, La Défense, France, 5Bristol-Myers Squibb, Rueil-Malmaison, France
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Vascular disease 2015 English
 
 
A COMPARISON OF TWO LOW-MOLECULAR-WEIGHT HEPARINS (LMWHS) IN TERMS OF COST PER PATIENT
Authors: Planellas L1, Miñarro C2, Restovic G1, Delgado M3, Rubio M3
Affiliations: 1IMS Health, Barcelona, Spain, 2IMS Health, Madrid, Spain, 3Sanofi, Barcelona, Spain
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Vascular disease 2015 English
 
 
Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain.
Authors: Gasche D1, Restovic G1, Casado V2, Ramírez-Boix P3, Martínez Lopez J3
Affiliations: 1IMS Health, Barcelona, Spain; 2Mataro Hospital, Mataro, Barcelona, Spain; 3Biogen, Madrid, Spain
Publications: 
Value in Health. Volume 18, Issue 7, November 2015, Page A755
Document Types: , Abstract
Countries: , Spain
Abstract: https://www.sciencedirect.com/science/article/pii/S1098301515050123?via%3Dihub
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Health economics, Neurological disorders 2015 English , Clinical setting: hospital, Cost effectiveness, Literature Review
 
 
A CROSS-SECTIONAL STUDY ON INSULIN TREATMENTS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES IN FRANCE, ITALY, GERMANY, UK AND SPAIN
Authors: Phan T1, Boutmy E2, Coulombel N2
Affiliations: 1Novo Nordisk Health Care AG, Zürich, Switzerland, 2IMS Health, Boulogne-Billancourt, France
Publications: 
ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.ispor.org/research_pdfs/51/pdffiles/PDB13.pdf
Condition Year Language Analysis type
, Diabetes 2015 English , Retrospective database analysis
 
 
Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland and Spain.
Authors: De Francesco M, Ronco C, Wacinski PJ, Wessely R, Hernández P, Lamotte M.
Affiliations: 
Publications: 
Document Types: 
Countries: , Germany, Italy, Poland, Spain
Abstract: http://dx.doi.org/10.3111/13696998.2015.1105809
Condition Year Language Analysis type
2015 English
 
 
Healthcare cost associated to constipation predominant irritable bowel syndrome in Spain
Authors: Raya A1, Barrull C2, Roset M2, Cortes X1, Fortea J1
Affiliations: 1Almirall S.A, Barcelona, Spain, 2IMS Health, Barcelona, Spain
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2014 English , Cost analysis
 
 
Description of GCSF usage in oncology in 5 European countries.
Authors: Anger C1, Schmidt N2, Ricarte C3
Affiliations: 1 IMS Health, London, United Kingdom 2 IMS Health, Frankfurt, Germany 3 IMS Health, La Defense, France
Publications: 
ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://meetinglibrary.asco.org/record/97923/abstract
Condition Year Language Analysis type
, Oncology 2014 English , Observational study
 
 
Evaluation of treatment patterns in acute nausea and vomiting in EU5 countries.
Authors: Schmidt N, Ricarte C, Haas G
Affiliations: 1 IMS Health CES Oncology, Central Europe; 2 Client Service Oncology, IMS Health France
Publications: 
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Evaluation-of-treatment-patterns-in-acute-nausea-and-vomiting-in-EU5-countries
Condition Year Language Analysis type
, Oncology 2014 English , Retrospective database analysis
 
 
Comparing patterns of BRAF testing and treatment in Metastatic Melanoma (MeM) in France, Germany, Italy, Spain and UK with the US.
Authors: Charnock J, Bruce A, Murch L, Anger C
Affiliations: Client Service Oncology, IMS Health, UK
Publications: 
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: poster-submission.com/cdrom/download_poster/37/27774/1110P
Condition Year Language Analysis type
, Oncology 2014 English , Retrospective database analysis
 
 
Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK.
Authors: Khanna R, Anger C
Affiliations: Client Service Oncology, IMS Health, UK
Publications: 
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Patterns-of-patients-stopping-their-anti-cancer-drug-due-to-its-associated-side-effects-in-France-Germany-Italy-Spain-and-UK-EU5
Condition Year Language Analysis type
, Oncology 2014 English , Retrospective database analysis
 
 
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.
Authors: Maina G, Ripellino C, Pegoraro V, Caresano C.
Affiliations: 
Publications: 
ISPOR Annual European Congress. 2014, Amsterdam
Value in health
Document Types: , Poster
Countries: , Italy, Spain
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(14)03164-7/abstract
Condition Year Language Analysis type
, Drug safety, Neurological disorders 2014 English , Real World Data
 
 
Patterns of systemic lupus erythematosus expression in Europe
Authors: Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12
Affiliations: 1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitié Salpetrière Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La Défense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France
Publications: 
Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629
Document Types: , Article, Manuscript in preparation
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders 2014 English , Epidemiological study, Observational study, Prospective study
 
 
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain.
Authors: Maina G1, Ripellino C2
Affiliations: 1 Department of Neurosciences, University of Torino, Torino, 2 CSD Medical Research S.R.L, Milan, Italy
Publications: 
Expert Opin Drug Saf. 2014 Sep;13(9):1149-54. doi: 10.1517/14740338.2014.943732. Epub 2014 Jul 18.
Document Types: , Article
Countries: , Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25036458
Condition Year Language Analysis type
, Mental health, Metabolic Disorders 2014 English , Retrospective database analysis
 
 
Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries
Authors: Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5
Affiliations: 
Publications: 
VALUE IN HEALTH 17 ; A684
Document Types: , Abstract
Countries: , Belgium, France, Germany, Italy, Spain
Condition Year Language Analysis type
, Health economics, Immunology and Vaccination, Oncology 2014 English , Cost of illness, Retrospective database analysis
 
 
Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review
Authors: Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6
Affiliations: 1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, München, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA
Publications: 
Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22–24 September, 2014 (Poster)
Document Types: , Abstract
Countries: , Germany, Netherlands, Spain, UK, USA
Condition Year Language Analysis type
, Oncology 2014 English , Literature Review
 
 
Afatinib in the treatment of EGFR mutation-positive NSCLC - A network meta-analysis.
Authors: Popat S1, Mok T2, Yang JC3, Wu YL4, Lungershausen J5, Stammberger U5, Griebsch I5, Fonseca T6, Paz-Ares L7
Affiliations: 1Royal Marsden Hospital, London, UK. 2State Key Laboratory of Southern China, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong. 3National Taiwan University, Taipei, Taiwan. 4Guangdong Lung Cancer Institute, Guangzhou, China. 5Boehringer Ingelheim GmbH, Ingelheim, Germany. 6IMS Health, London, UK. 7Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del Rocío, US, CSIC), Seville, Spain.
Publications: 
Lung Cancer. 2014 Aug;85(2):230-8
Document Types: , Article
Countries: , China, Germany, Hong Kong, Spain, Taiwan, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24929780
Condition Year Language Analysis type
, Oncology 2014 English , Meta analysis
 
 
The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom: Is Current Practice Consistent with the 2012 ESC Recommendations.
Authors: COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M
Affiliations: (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France
Publications: 
16th Annual European ISPOR Congress Dublin, Ireland
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03127-6/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2013 English , Retrospective database analysis
 
 
The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥ 30 kg/m2 in Spain
Authors: Fonseca T1, Clegg J2, Caputo G3, Norrbacka K4, Dilla T5, Alvarez M5
Affiliations: 1IMS Health, London,UK, 2IMS Health, Basel, Switzerland, 3IMS Health, Keppel Towers, Singapore, 4dEli Lilly Finland Ab, , Helsinki, Finland, 5eLilly SA, Spain
Publications: 
J Med Econ. 2013 Jul;16(7):926-38
Document Types: , Abstract
Countries: , Spain
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696998.2013.803110
Condition Year Language Analysis type
, Diabetes 2013 English , Cost effectiveness
 
 
Cost per treated patient for biologics for rheumatoid arthritis (RA) using US claims data.
Authors: Schabert VF1, Korn JR1, Bilir SP1, DeKoven M1, Harrison DJ2, Joseph G2
Affiliations: 1 IMS Health, Alexandria, USA, 2 Amgen Inc, Thousand Oaks, USA
Publications: 
European League Against Rheumatism 2013 Congress, Madrid, Spain
Document Types: , Poster
Countries: , Spain, USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost analysis
 
 
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
Authors: Curtis JR1, Schabert VF2, Harrison DJ3, Yeaw J2, Korn JR2, Quach C4, Yun H5, Joseph GJ3, Collier DH6.
Affiliations: 1Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama; Department of Epidemiology, University of Alabama, Birmingham, Alabama. Electronic address: jcurtis@uab.edu. 2IMS Health, Alexandria, Virginia. 3Global Health Economics, Amgen Inc, Thousand Oaks, California. 4Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina. 5Department of Epidemiology, University of Alabama, Birmingham, Alabama. 6Inflammation/Development, Amgen Inc, Thousand Oaks, California.
Publications: 
Clin Ther. 2014 Jul 1;36(7):996-1004.
Document Types: 
Countries: , Spain, USA
Condition Year Language Analysis type
, Rheumatology 2013 English , Cost effectiveness
 
 
Direct Costs of Unintended Pregnancy in Spain
Authors: Lete I1, Hassan F2, Chatzitheofilou I2, Mendivil J3, Bofill A3, Restovic G3, Arbat A3, Filonenko A4
Affiliations: 1Hospital Universitario Araba, Spain; 2IMS Health, UK; 3Bayer Hispania SL, Spain; 4Bayer Pharma AG, Germany
Publications: 
15th World Congress on Human Reproduction Venice, Italy, 13 – 16 March, 2013, ID # 400, Topic: 14. Contraception
Document Types: , Poster
Countries: , Spain
Abstract: http://www.humanrep2013.com/pdf/HR2013-digital%20edition.pdf
Condition Year Language Analysis type
, Womens Health 2013 English , Cost analysis, Cost of illness
 
 
Current emesis Patterns of chemotherapy and antiemetic treatments in Western Europe.
Authors: Ricarte C, Anger C
Affiliations: 1 IMS Health, France 2 IMSHealth, UK
Publications: 
ESMO 2013
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
2013 English , Retrospective database analysis
 
 
Management costs of the first five years after diagosis in Breast Cancer by Stage in France.
Authors: Atsou L, Bardoulat I, Colin X, Lemasson H, Ricarte C, Maurel F, Ajjouri R, Lancon F
Affiliations: 1 IMS Health, La Defense, France, 2 French National Cancer Institute, Boulogne-Billancourt France Cedex, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02369-3/abstract
Condition Year Language Analysis type
, Oncology 2013 English , Retrospective cohort analysis
 
 
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English , Retrospective database analysis
 
 
Current situation of oral anticancer treatments use in France: the ACTOR Study.
Authors: Benjamin L, Maurel F, Bardoulat I, Ricarte C
Affiliations: 1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Abstract
Countries: , China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext
Condition Year Language Analysis type
, Oncology 2013 English
 
 
Evolution of Molecular Diagnostic test Usage in Solid tumours in EU5 (Analysis of Molecular Biomarker Tests in Oncology).
Authors: Ricarte C, Bruce A, Anger C
Affiliations: 1 IMS Health, La Defense, France 2 IMS Health, London, United Kingdom
Publications: 
ISPOR Europe 2013 Annual meeting
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02310-3/pdf
Condition Year Language Analysis type
, Oncology 2013 English , Retrospective database analysis
 
 
The association between asthma control, health care costs, and quality of life in france and Spain.
Authors: Doz M1, Chouaid C, Com-Ruelle L, Calvo E, Brosa M, Robert J, Decuypère L, Pribil C, Huerta A, Detournay B.
Affiliations: 1Cemka-Eval, 43 Boulevard du Maréchal Joffre, Bourg-la-Reine
Publications: 
BMC Pulmonary Medicine 2013, 13:15
Document Types: , Article
Countries: , France, Spain
Condition Year Language Analysis type
, Respiratory disease 2013 English , Cost analysis, Prospective study, Retrospective database analysis
 
 
Costes de los agentes estimulantes de la eritropoyesis en el tratamiento de la anemia inducida por quimioterapia en España: resultados preliminares procedentes de la adaptación de un estudio belga
Authors: Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutiérrez L5, Restovic G6
Affiliations: 1IMS Health, London, 2SBD Analytics, Belgium, 3IMS Health, Belgium, 4Oblikue Consulting, Spain, 5Amgen SA, Spain, 6Independant Consultant, Spain
Publications: 
Pharmacoecon Span Res Artic (2014) 11:15–23
Document Types: , Article
Countries: , Spain
Abstract: https://link.springer.com/article/10.1007/s40277-013-0022-7
Condition Year Language Analysis type
, Hematology 2013 Spanish , Cost analysis
 
 
ADHERENCE TO TREATMENT AND PERSISTENCY IN PATIENTS TREATED WITH VKA IN FRANCE, ITALY, GERMANY, SPAIN AND UK
Authors: COTTÉ FE1, CARRASCO J1, DUPRATLOMON I1, MARCHANT N2, LETIERCE A3 & HUGUET M3
Affiliations: (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France
Publications: 
ISPOR Annual European Congress, Dublin. 2013.
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2013 English , Retrospective database analysis
 
 
Anticoagulation treatment with VKA in France, Italy, Germany, Spain and UK. Results from the REACT-AF study.
Authors: COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M
Affiliations: (1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France
Publications: 
ISPOR Annual European Congress, Dublin. 2013
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2013 English , Retrospective database analysis
 
 
Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain.
Authors: Huguet M, Shakespeare A, Haug HM, Miadi-Fargier H, Restovic G, Rafols C, Kempf C
Affiliations: 
Publications: 
ISPOR Annual European Congress, Berlin, Germany
Document Types: , Poster
Countries: , France, Spain
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)02765-9/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2012 English , Pricing & Reimbursement
 
 
Major surgery in patients with metastatic colorectal cancer in western Europe.
Authors: Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Klingman D3, Gao S1
Affiliations: 1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA
Publications: 
J Gastrointest Cancer. 2012 Sep;43(3):456-61
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22125088
Condition Year Language Analysis type
, Oncology 2012 English , Retrospective database analysis
 
 
Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe.
Authors: Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Gao S1, Klingman D3
Affiliations: Amgen Inc., Thousand Oaks, CA, USA1, IMS Consulting Group, Watertown, MA, USA2, IMS Consulting Group, Alexandria, VA, USA3
Publications: 
Curr Med Res Opin 2012; 28(2):221-229; 2012 Jan 27 [Epub ahead of print]
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2012 English , Retrospective database analysis
 
 
Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries
Authors: Duran A1, Spaepen E2,Lamotte M3, Walter E4, Umuhire D5, Lucioni C6, Pinheir B7, Brosa M8, Pujol LKB9, Van Belle S10, Annemans L11
Affiliations: 1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Pharmaeconomic Research, Health Economics, Vienna, Austria 5 IMS Health, Paris, France 6 Wolters Kluwer Health Italy, Milan, Italy 7 CISEP, Research Centre on the Portuguese Economy, Lisbon, Portugal 8 Oblikue Consulting, Barcelona, Spain 9 Amgen (Europe) GmbH, Zug, Switzerland 10 Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium 11 I-CHER, Ghent University, Brussels University (VUB), Ghent, Belgium
Publications: 
Journal of Medical Economics Vol. 15, No. 3, 2012, 1–10
Document Types: , Article
Countries: , Austria, Belgium, France, Italy, Spain
Condition Year Language Analysis type
, Hematology 2012 English , Cost analysis
 
 
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey.
Authors: DeKoven M, Bonthapally V, Lee W, Pathak P, Jiao X, Ray S, Alexandria
Affiliations: IMS Health; Abbott Laboratories, Abbott Park, IL; IMS Health, Collegeville, PA
Publications: 
ASCO 2012; J Clin Oncol 30, 2012 (suppl; abstr 570)
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.570
Condition Year Language Analysis type
, Oncology 2012 English , Retrospective database analysis
 
 
Cost-Effectiveness of Tapentadol in Severe Chronic Pain in Spain: A Cost Analysis of Data From RCTs
Authors: Obradovic M1, Ikenberg R2, Hertel N3, Antoñanzas F4, Gálvez R5, Liedgens H1
Affiliations: 1 Grünenthal GmbH, Aachen, Germany 2 IMS Health Economics and Outcomes Research, Munich, Germany 3 IMS Health Economics and Outcomes Research, London, UK 4 Department of Economics and Business, University of La Rioja, Logroño, Spain 5 Pain and Palliative Care Unit, University Hospital Virgen de las Nieves, Granada, Spain
Publications: 
Clinical Therapeutics/Volume 34, Number 4, 2012
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2012 English , Cost effectiveness
 
 
Assessing the budget impact of using ScanBag® in CT in 6 European countries.
Authors: Nivelle E1, Mathou F2, Lamotte M1
Affiliations: 1 IMS Health, Vilvoorde, Belgium 2 Guerbet SA, Villepinte, France
Publications: 
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany
Document Types: , Abstract, Poster
Countries: , Belgium, France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Miscellaneous 2012 English , Budget impact
 
 
Cost-effectiveness of Rivaroxaban versus Acenocumarol in the stroke prevention in patients with Non-Valvular Atrial Fibrilation in the Spanish setting
Authors: Restovic G1, Carcedo D1, McLeod EJ2, Guillermin ALG3, Evers T4
Affiliations: 1Bayer Pharma, Barcelona-Spain, Barcelona, Barcelona, Spain, 2IMS Health, London, UK, 3IMS Health, London , UK, 4Bayer Schering Pharma AG, Wuppertal, Germany
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx
Condition Year Language Analysis type
, Cardiovascular disease 2012 English , Cost effectiveness
 
 
The impact of Atrial Fibrilation symptoms in the health related quality of life in Spanish population (Ulises Study)
Authors: Arribas F1, Montull E2, LLobet X2, Perulero N3, Badia X4
Affiliations: 1Hospital Universitario 12 de Octubre, MADRID, Spain, 2SANOFI AVENTIS S.A., BARCELONA, Spain, 3IMS Health, S.A., Barcelona, Spain, 4IMS Health, Barcelona, Spain
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx
Condition Year Language Analysis type
, Cardiovascular disease 2012 English , Quality of life
 
 
Cost of Erythropoiesis-stimulating Agents (ESAs) in the treatment of Chemotherapy-related Anaemia in Spain
Authors: Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G6, Annemans L7
Affiliations: 1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Oblikue Consulting, Barcelona, Spain 5 Amgen S.A., Barcelona, Spain; 6 Independent Consultant, Barcelona, Spain 7 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2012 English , Cost of illness
 
 
Preliminary validation of collect scale: a co-morbidity assessment tool for patients with Chronic Lymphocytic Leukaemia
Authors: Giraldo P1, Lopez A2, Rios E3, Gonzalez-Grande I4, Roset M5, Castro-Gomez A6, De La Serna J7, Carbonell F8
Affiliations: 1Hospital Universitario Miguel Servet, Zaragoza, Spain, 2Hospital Universitari Valle d'Hebron, Barcelona, Spain, 3Hospital Virgen de Valme, Sevilla, Spain, 4Roche Farma, S.A., Madrid, Spain, 5IMS Health, Barcelona, Spain, 6Roche, Madrid, Spain, 7Hospital Universitario 12 de Octubre, Madrid, Spain, 8Consorci Hospital General Universitari Valencia, Valencia, Spain
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition Year Language Analysis type
, Oncology 2012 English
 
 
Improvements in Health-Related Quality of life in Acromegaly with Pasireotide LAR and Octreotide LAR: Results from a large, randomized, Double-Blind Phase III Trial
Authors: Badia X1, Forsythe A2, Nelson LM3, Coles TM3, McLeod LD3, Webb SM4
Affiliations: 1IMS Health, Barcelona, Barcelona, Spain, 2Novartis Pharmaceuticals, East Hanover, NJ, USA, 3RTI Health Solutions, Research Triangle Park, NC, USA, 4Hospital Sant Pau and CIBERER 747, Universitat Autònoma de Barcelona, Barcelona, Spain
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters4.aspx
Condition Year Language Analysis type
, Endocrinology 2012 English , Prospective study
 
 
Cost-Effectiveness of Plerixafor plus GCSF for Mobilization of Peripheral blood Stem Cells in Patients with Myeloma and Lymphoma in Spain
Authors: Duarte RF1, Pérez-Simón JA2, Martín G3, de la Rubia J4, Marín P5, Álvarez MA6, Espinós B7, Roset M7
Affiliations: 1Institut Català D'Oncologia - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Spain, 2Hospital Universitario Virgen del Rocío, Sevilla, Spain, 3Banc de Sang i Teixits, Barcelona, Spain, 4Hospital Universitario La Fe de Valencia, Valencia, Spain, 5Hospital Clínic, Barcelona, Spain, 6Hospital Reina Sofía, Córdoba, Spain, 7IMS Health, Barcelona, Spain
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters3.aspx
Condition Year Language Analysis type
, Oncology 2012 English , Cost effectiveness
 
 
Validation of a new tool to assess health-realted quality of life psoriasis: the PSO-LIFE questionnaire.
Authors: Dauden E,Herrera E, Puig L, Sánchez-Carazo J, Toribio J, Caloto Mª, Nocea G, Roset M, Lara N.
Affiliations: 1 Department of Dermatology, University of Hospital of Princess,Madrid 2 Department of Dermatology, University of Hoapital Virgen of the Victory, Málaga 3 Department of Dermatology, Hospital Santa Creu i Sant Pau, Barcelona 4 Department of Dermatology, Hospital General of Valencia, Valencia 5 Department of Dermatology, Hospital Gil Casares, Santiago of Compostela 6 Outcomes Research, MSD, Madrid 7 IMS Health, Barcelona
Publications: 
Health Qual Life Outcomes. 2012 May 24;10:56
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Validation%20of%20a%20new%20tool%20to%20assess%20health-realted%20quality%20of%20life%20psoriasis%3A%20the%20PSO-LIFE%20questionnaire.
Condition Year Language Analysis type
, Dermatology 2012 English , Quality of life
 
 
Psychometric performance of the CushingQol questionnaire in conditions of real clinical practice.
Authors: Santos A, Resmini E, Martínez-Momblán MªA, Crespo I, Valassi E, Roset M, Badia X, Webb S.
Affiliations: Health Economics and Outcomes Research, IMS Health, Barcelona, Hospital Sant Pau, Center of Biomedical Investigation in rare diseases.
Publications: 
Eur J Endocrinol. 2012 Sep;167(3):337-42
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Psychometric%20performance%20of%20the%20CushingQol%20questionnaire%20in%20conditions%20of%20real%20clinical%20practice.
Condition Year Language Analysis type
, Endocrinology 2012 English , Quality of life
 
 
Practice patterns in the management of prostate cancer in spain: results from a National Survey Among Radiation oncologists in 2009
Authors: Zapatero A, López-Torrecilla J, Herruzco I, Calvo FA.
Affiliations: Department of Radiation Oncology, Health Research Institute IP, Hospital University of Princess, Madrid.
Publications: 
Clin Transl Oncol. 2013 Mar;15(3):226-32
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Practice%20patterns%20in%20the%20management%20of%20prostate%20cancer%20in%20spain%3A%20results%20from%20a%20National%20Survey%20Among%20Radiation%20oncologists%20in%202009
Condition Year Language Analysis type
, Oncology 2012 Spanish , Survey research
 
 
Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations?
Authors: Alvar A, Soler J, Molina J, Muñoz MJ, García-Losa M, Roset M, Jones PW, Badia X.
Affiliations: Hospital of Clinic IDIBAPS, Barcelona & Ciber Respiratory diseases, Barcelona, Hospital of Requena, Neumonology Unit, Center if Health French,Spain, GlaxoSmithkline S.A. Medical, Spain, IMS Health, Barcelona, St. George´s Hospital Medical School, Respiratory Medicine, University of London, UK.
Publications: 
COPD. 2012 Aug;9(5):492-8
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=is%20the%20cat%20questionnaire%20sensitve%20to%20changes%20in%20health%20status%20in%20patients%20with%20severe%20copd%20exacerbations
Condition Year Language Analysis type
, Respiratory disease 2012 English
 
 
Retrospective chart review study of the cost of care of systematic lupus erythematousus (SLE)in 5 European coutries
Authors: Doria A1, Amoura Z 2, Richter J3, Cervera R4, Khamashta M5, Guillemin F6, Garofanno A7, Maurel F7, Roset M8, Perna A9, Schmitt C10, Ager M9, Boucot I11, Gonzalez MC Quire S10, Birch H10.
Affiliations: 1. University of Padova, Padova, Italy, 2. Université Paris VI Pierre et Marie Courie, Paris, France, 3. Heinrich-Heine-University, Düsseldorf, Germany, 4. Hospital Clinic, Barcelona, Spain, 5. The Rayne Institute, London, United Kingdom, 6. Centre d'épidémiologie clinique, Vandoeuvre-les-Nancy, France, 7. IMS Health, Paris, France, IMS Health, Barcelona, Spain, 9. GlaxoSmithKline, Brentford, United Kingdom, 10. GlaxoSmithKline, Uxbrige, United Kingdom, 11. GlaxoSmithKline, Marly-le-Roi, France
Publications: 
Abstract - Presentation PSY17 for the 14th European congress of ISPOR 2011
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Immunology and Vaccination 2011 English , Cost analysis, Cost of illness, Epidemiological study, Observational study, Retrospective cohort analysis
 
 
Costs of tumor necrosis factor blockers per treated patient across adult indications using real-world data in US commercially-insured population.
Authors: Schabert V1, Gandra SR2, Watson C2, Fox KM3, Yeaw J4, Goodman S4, Milev S5, Harrison DJ2.
Affiliations: 1IMS Health, Falls Church, VA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA, 3Strategic Healthcare Solutions, LLC, Monkton, MD, USA, 4IMS Health, Watertown, MA, USA, 5IMS Brogan, A unit of IMS, Ottawa, ON, Canada
Publications: 
14th Annual European Congress, International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Spain1111/Posters1.aspx
Condition Year Language Analysis type
, Rheumatology 2011 English , Budget impact
 
 
Cost Analysis: Treatment of Chemotherapy-induced Anaemia with Erythropoiesis-Stimulating Agents (ESAS) in Spain
Authors: Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutierrez L5, Restovic G5, Annemans L6
Affiliations:  1IMS Health, London, UK, 2SBD Analytics BVBA/SPRL, Bekkevoort, Belgium, 3IMS Consulting Group, Vilvoorde, Belgium, 4Oblikue Consulting, Barcelona, Spain, 5Amgen S.A., Barcelona, Spain, 6Ghent University, Ghent, Belgium
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2011 English , Cost analysis
 
 
Regional variability in the generic antidepressant market in Spain
Authors: Espinós B, Vieta A, Hurtado P, Badia X
Affiliations: IMS Health, Barcelona, Spain
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Mental health 2011 English , Epidemiological study
 
 
Market access barriers for Biosimilars in Spain and Germany: Epoetin Alfa Example
Authors: Hurtado P, Vieta A, Espinós B, Badia X
Affiliations: IMS Health, Barcelona, Spain
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Germany, Spain
Condition Year Language Analysis type
, Pricing and reimbursement 2011 English , Market impact
 
 
Regional differences among Methadone maintenance programs in Spain
Authors: Vieta A, Hurtado P
Affiliations: IMS Health, Barcelona, Spain
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health policy 2011 English , Prospective study
 
 
Cost-effectiveness of Roflumilast (Daxas®) in the treatment of chronic obstructive pulmonary disease (COPD) in Spain.
Authors: Lindner L1, Camins de Valdenebro L2, Aparicio Martinez J2
Affiliations: 1IMS Health, Barcelona, Cataluña, Spain, 2Nycomed Pharma S.A., Madrid, Madrid, Spain
Publications: 
ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PRS34
Condition Year Language Analysis type
, Respiratory disease 2011 English , Cost effectiveness
 
 
Surgery in patients with metastatic colorectal cancer in western Europe.
Authors: Z. Zhao, E. M. Pelletier, B. Barber, M. Bhosle, S. Wang, D. Klingman, S. K. Gao; Amgen Inc., Thousand Oaks, CA; IMS Health, Inc., Watertown, MA; IMS Health, Inc., Falls Church, VA
Affiliations: 1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA
Publications: 
2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2011, Chicago, IL, USA
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Condition Year Language Analysis type
, Oncology 2011 English , Retrospective database analysis
 
 
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.
Authors: Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7, Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10, Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2
Affiliations: 1 Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2 CIBER of Epidemiology and Public Health, Madrid, Spain; 3 Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8 Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; 9 Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003 Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium
Publications: 
Eur Heart J. 2011 Sep;32(17):2143-52
Document Types: , Article
Countries: , Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21471134
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Observational study, Prospective study
 
 
Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe.
Authors: Papageorgiou G1, Cañas F, Zink M, Rossi A.
Affiliations: 1Department of Psychiatry, Evangelismos General Hospital
Publications: 
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):17-28. doi: 10.1016/S0924-9338(11)71710-2.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440220
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.
Authors: Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F.
Affiliations: 
Publications: 
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
Document Types: , Article
Countries: , Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21923932
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Observational study, Prospective study
 
 
Factors associated with hospitalisation of patients with schizophrenia in four European countries.
Authors: Gorwood P1.
Affiliations: 1CMME, Sainte-Anne Hospital, University Paris Descartes
Publications: 
Eur Psychiatry. 2011 May;26(4):224-30. doi: 10.1016/j.eurpsy.2011.02.012. Epub 2011 Mar 23.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21429717
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Patients with schizophrenia : results of a physician-based survey conducted in four European countries (Germany, Greece, Italy and Spain).
Authors: Gorwood P1.
Affiliations: 1CMME, Sainte-Anne Hospital, University Paris Descartes
Publications: 
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):1.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Use of ziprasidone in patients with schizophrenia in four European countries.
Authors: Montes JM1.
Affiliations: 1Hospital del Sureste, Arganda del Rey, Spain
Publications: 
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):29-37. doi: 10.1016/S0924-9338(11)71711-4.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440221
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAs) in patients with cancer receiving chemotherapy: a multi-country approach.
Authors: Duran A1, Spaepen E2, Lamotte M3, Walter E4, Lucioni C5, Pinheiro B6, Brosa M7, Kutikova L8, Pujol B8, Annemans L9
Affiliations: 1 IMS Health, London, United Kingdom 2 SBD Analytics, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Parmacoeconomic Research, Vienna, Austria 5 Wolters Kluwer Health Italy, Milan, Italy 6 Centre de Investigaçao Sobre Economia Portuguesa, Lisboa, Portugal 7 Oblikue Consulting, Barcelona, Spain 8 Amgen (Europe), Zug, Switzerland 9 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium
Publications: 
ISPOR 14th Annual European Congress 5-8 November 2011, Madrid, Spain
Document Types: , Poster
Countries: , Austria, Italy, Portugal, Spain
Condition Year Language Analysis type
, Oncology 2011 English , Cost analysis
 
 
Genotyping in patients in treatment with acenocumarol cost-effectiveness
Authors: Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3
Affiliations: Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 2 Servicio de Hemoterapia y Hemostasia, Hospital Clinic Barcelona, 3 Progenika Biopharma S.A.
Publications: 
Revista Española de Economia de la Salud; 8(2): 77-84
Document Types: , Article
Countries: , Spain
Abstract: http://www.economiadelasalud.com/ediciones/82/08_pdf/acenocumarol.pdf
Condition Year Language Analysis type
, Cardiovascular disease 2010 Spanish
 
 
Treatment cost of hemophilia patients with inhibitors in the National Health System in Morocco
Authors: El Khorassani M, Hadjkhalifa H, By Z, Plun-Favreau J, Lindner L, Prior M.
Affiliations: 
Publications: 
Espérance Méd 2010; 17: 101-7.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Hematology 2010 Spanish , Cost effectiveness
 
 
Agreements with pharmaceutical industry: “Paying pay for results”
Authors: Badia X, Prior M.
Affiliations: 
Publications: 
Farm Hosp.2010;34(2):53–55.
Document Types: , Article
Countries: , Spain
Abstract: http://www.sefh.es/fh/105_121v34n02pddf001.pdf
Condition Year Language Analysis type
, Health economics 2010 Spanish , Cost effectiveness
 
 
Prevalence of the Metabolic Syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain.
Authors: Rodríguez A, Polavieja P, Reviriego J.
Affiliations: 
Publications: 
Endocrinol Nutr. 2010; 57(45):60-70.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Endocrinology 2010 Spanish , Burden of illness
 
 
Direct medical cost of Crohn disease in Spain.
Authors: Casellas F, Panés J, García-Sanchez V, Ginard D, Gomollón F, Hinojosa J, Marín-Jiménez I, Barreiro M, Bastida G, Lindner L, Giménez E, Vieta A.
Affiliations: 
Publications: 
Pharmacoeconomics Spanish Research Articles 2010;7(5):38-46.
Document Types: , Article
Countries: , Spain
Abstract: http://adisonline.com/pecspanish/Articles/Vol%207%20Issue%201%20page%2038-46%202010.pdf
Condition Year Language Analysis type
, Endocrinology 2010 Spanish , Cost consequence
 
 
Regionalization of Market research. Why should it be evidence-based.
Authors: Badia X, Sabater J.
Affiliations: 
Publications: 
PM Farma 2010;XVII(105):54-55.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2010 Spanish , Cost analysis
 
 
Impact of nocturia in the sleep quality in patients diagnosed of LUTS/BPH.
Authors: Hernández C, Estivill E, Cantalapiedra A.
Affiliations: 
Publications: 
Actas Urol Esp.2010;34(5):450-9.
Document Types: , Article
Countries: , Spain
Abstract: http://scielo.isciii.es/pdf/aue/v34n5/original5.pdf
Condition Year Language Analysis type
, Urology 2010 Spanish , Methodology
 
 
Mirror questionnaire. Satisfaction value in Ostomized patients with the Health Care and dispositive.
Authors: Arias Alvarez M, Fernandez-García M.A., Gonzalez-Buenadicha AM, Pastor-Juan C, Payeras-Gelabert M, Perez-Salazar I, Real-Romaguera A, Rivas-Marín C, Ruiz-Fernandez MD, Sanchez-Crisol I, Sanchez de la Blanca-Martín MI, Espirac B, García-Alamino JM, Perulero N.
Affiliations: 
Publications: 
Revista Rol de Enfermeria 2010;33(5):328-337.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Urology 2010 Spanish , Methodology
 
 
Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP
Authors: Chacón García A, Ruigómez A & García Rodríguez LA
Affiliations: Medicina Preventiva y Gestión de Calidad, Hospital General Universitario Gregorio Marañón, Madrid, Spain
Publications: 
Aten Primaria. 2010 Nov;42(11):543-9. doi: 10.1016/j.aprim.2010.05.004. Epub 2010 Sep 15
Document Types: , Abstract
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20833449
Condition Year Language Analysis type
, Infectious disease, Respiratory disease 2010 English , Retrospective database analysis
 
 
Comparison of Prescribing Patterns for Asthma in Five European Countries
Authors: Laforest L, Schwalm MS, Dufour M, Broquet M, Bourke A & Van Ganse E
Affiliations: Cegedim
Publications: 
ICPE 2010
Pharmacoepidemiology and Drug Safety (19): S1-S347
Document Types: , Abstract, Poster
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13
Condition Year Language Analysis type
, Respiratory disease 2010 English , Retrospective database analysis
 
 
Validation of the AF-QOL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.
Authors: Arribas F1, Ormaetxe JM2, Peinado R3, Perulero N4, Ramírez P5, Badia X4
Affiliations: 1Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain 2Unidad de Arritmias. Servicio de Cardiología, Hospital de Basurto. Bilbao, Spain 3Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain 4Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 5MEDA Pharma; Madrid, Spain
Publications: 
Europace. 2010;12(3):364-70.
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Abstract: http://europace.oxfordjournals.org/cgi/content/abstract/eup421
Condition Year Language Analysis type
, Cardiovascular disease 2010 English , Observational study, Prospective study, Quality of life
 
 
Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population.
Authors: Asukai Y1, Valladares A2, Camps C3, Wood E1, Taipale K4, Arellano J4, Cassinello A2, Sacristan JA2, Dilla T2.
Affiliations: 1 IMS Health, London, UK 2 Eli Lilly SA, Madrid, Spain 3 Hospital General Universitario, Valencia, Spain 4 Eli Lilly, Windlesham, Surrey, UK
Publications: 
BMC Cancer. 2010 Jan 29;10:26
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20113499
Condition Year Language Analysis type
, Oncology 2010 English , Cost effectiveness
 
 
Spectacle independence and subjective satisfaction of ReSTOR® multifocal intraocular lens after cataract or presbyopia surgery in two European countries
Authors: Cochener B1, Fernández-Vega L2, Alfonso JF2, Maurel F3, Meunier J4, Berdeaux G5,6
Affiliations: 1 Centre Hospitalier de Brest, Brest, France; 2 Instituto Oftalmologico Fernandez Vega, Oviedo, Spain; 3 IMS Health, Health Economics Department, Puteaux, France; 4 Mapi Values, Lyon, France; 5 Alcon France, Health Economics Department, Rueil-Malmaison, France; 6 Conservatoire National des Arts et Métiers, Paris, France
Publications: 
Clin Ophthalmol. 2010 Mar 4;4:81-9.
Document Types: , Manuscript in preparation
Countries: , France, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Cochener+B%5Bfirst+author%5D+AND+spectacle&TransSchema=title&cmd=detailssearch
Condition Year Language Analysis type
, Ophthalmology 2010 English , Retrospective cohort analysis, Survey research
 
 
Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain.[Spanish].
Authors: Domingo J, Lara N , Malé N, Betegón L, Largeron N, Tricchard M.
Affiliations: 1. Vaccine Investigation Area. CSISP Centre for Public Health Research, Avda Catalunya 21, Valencia, (46020), Spain. 2. HEOR, IMS Health, Dr. Ferran 25 - 27,Barcelona, (08034), Spain. 3. Market Access Manager Sanofi PasteurMSD, SNC, 8, Rue Jonas Salk, Lyon,(69367), France.
Publications: 
BMC Public Health 2010, 10:469
Document Types: , Article
Countries: , Spain
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927540/
Condition Year Language Analysis type
, Gastrointestinal disorders 2010 Spanish , Burden of illness
 
 
Recent trends in COPD prevalence in Spain: a repeated cross-sectional Survey 1997-2007.
Authors: Soriano JB1, Ancochea J, Miravitles M, García-Río F, Duran-Tauleria E, Muñoz L, Jiménez-Ruíz C.A, Masa J.F, Viejo J.L, Villasante C, Fernández- Fau L, Sánchez G, Sobradillo-Peña V.
Affiliations: 1Fundació Caubet-CIMERA, Illes Balears, Mallorca, Spain
Publications: 
Eur Respir J 2010; 36: 758-765.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2010 English , Survey research
 
 
Cost Evaluation study of oral treatment with Xeloda and Tarceva compared to intravenous chemotheraphy from the perspective of a Spanish private insurance company
Authors: Benito A1, Caballo B2, Gomez J2, Moyano N3, Gimenez E4, Prior M4.
Affiliations: 1 Mapfre Familiar, 2 H. U.Madrid Sanchinarro, 3Hospital QuirónMadrid, 4 IMS Health, barcelona, Spain
Publications: 
Revista Española Economía de la Salud 2010;9(1):28-36
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2010 Spanish , Economic evaluation
 
 
Differences in quality of life according to the type of atrial fibrillation [Spanish].
Authors: Peinado R1, Arribas F2, Ormaetxe JM3, Badia X4.
Affiliations: 1 Hospital Universitario La Paz, Madrid, Spain 2 Hospital Universitario 12 de Octubre, Madrid, Spain 3 Hospital Universitario de Basurto, Bilbao, Vizcaya, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
Revista Esp. Cardiol. 2010; 63: 1402-1409
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2010 Spanish , Quality of life
 
 
Impacto de la introducción de alitretinoína oral en los costes del eczema de las manos severo de origen profesional desde la perspectiva de las Mutuas de Accidentes de Trabajo y Enfermedades Profesionales en España.
Authors: Manuel Mascaró J, Quero Nasarre I, Lindner L, Prior M, Oliver J, Halbach R.
Affiliations: Manuel Mascaró J1, Quero Nasarre I2, Lindner L3, Prior M3, Oliver J4, Halbach R4. 1Servicio de Dermatología, Hospital Clínic de Barcelona. 2Servicio de Dermatología. MAZ de Zaragoza. 3IMS Health. 4Basilea Pharmaceuticals Iberia, S. L.
Publications: 
Rev. SEMST 2010; 5(1): 9-18
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Abstract: http://dialnet.unirioja.es/servlet/articulo?codigo=3161177
Condition Year Language Analysis type
, Dermatology, Health economics 2010 Spanish , Cost analysis, Cost consequence
 
 
The Economic Impact of Overactive Bladder Syndrome in Six Western Countries.
Authors: Irwin DE1, Mungapen L2, Milsom I3, Kopp Z4, Reeves P2, Kelleher C5
Affiliations: 1Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, US 2 IMS Health incorporating Fourth Hurdle Consulting Ltd, London, UK 3 Department of Obstetrics & Gynaecology, Sahlgrenska Academy at the University of Gothenburg, Sweden 4 Pfizer Inc., New York, USA, , 5 Department of Obstetrics and Gynaecology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Publications: 
British Journal of Urology International (BJU International), 103(2):202-209
Document Types: , Article
Countries: , Canada, Germany, Italy, Spain, Sweden, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19278532?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1
Condition Year Language Analysis type
, Overactive bladder 2009 English , Budget impact
 
 
Does pharmaceutical consumption improve healthcare status?
Authors: Grandfils N1, Hauser S1, Amalric F1, Le Pen C2
Affiliations: 1IMS Health, Puteaux, France, 2Paris Dauphine University, Paris, France
Publications: 
ISPOR 12th Annual European Congress, Paris, France, 24–27th October 2009
Document Types: , Abstract, Poster
Countries: , Denmark, France, Germany, Italy, Spain, Sweden, UK
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx
Condition Year Language Analysis type
, Health policy 2009 English , Economic evaluation
 
 
Cost-effectiveness of biologic treatments for moderate to severe psoriasis
Authors: Carretero G1, Moreno JC2, Notario J3, Silvestre JF4, López-Belmonte JL5, Giménez E6, Sabater FJ7, Fonseca E8
Affiliations: 1Hospital Dr. Negrín, Las Palmas de Gran Canarias, Las Palmas de Gr, Spain, 2Hospital Reina Sofía, Córdoba, Andalucía, Spain, 3Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain, 4Hospital General de Alicante, Alicante, Alicante, Spain, 5Schering Plough S.A, Alcobendas, Madrid, Spain, 6IMS Health, Barcelona, Spain, 7Schering- Plough S.A, Alcobendas, Spain, 8Complejo Hospitalario Universitario Juan Canalejo, A Coruña, A Coruña, Spain
Publications: 
ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France
Document Types: , Abstract, Poster
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2009 English , Cost utility
 
 
Traducción y adaptación cultural de la versión española del cuestionario EQ-5D-Y en niños y adolescentes. [Tanslation and Cultural Adaptation of the Spanish Version of EQ-5D-Y Questionnaire for Children and Adolescents]
Authors: Gusi N1, Badia X2, Herdman M3, Olivares PR1.
Affiliations: 1Facultad deCienciasdelDeporte,UniversidaddeExtremadura,Cáceres,España 2Health OutcomesResearchEurope,Barcelona,España 3Institut Municipal d’Investigació Mèdica(IMIM),Barcelona,España
Publications: 
Aten Primaria. 2009;41(1):19-23.
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19187838
Condition Year Language Analysis type
, Pediatrics 2009 Spanish , Quality of life
 
 
Percepción de los médicos de Atención Primaria en el manejo clínico de la osteoporosis. Influencia de los Planes de Salud. [Primary care perception of clinical management of osteoporosis. The influence of healthcare policies]
Authors: Carbonell Abella C, Abizanda González M, Pérez Hernández M, Roset Gamisans M, Nogués Solán X
Affiliations: Carbonell Abella C1, Abizanda González M2, Pérez Hernández M3, Roset Gamisans M4, Nogués Solán X5 1 Centro de Salud Vía Roma. Barcelona. Facultad de Medicina. Universidad de Barcelona. España. 2 Centro de Atención Primaria Vila Olímpica. Barcelona. España. 3 Laboratorios Almirall. Barcelona. España. 4 IMS Health. Barcelona. España. 5 eUnidad de Investigación de Fisiopatología Ósea y Articular del Institut Municipal d'Investigacions Mèdiques (IMIM). Departamento de Medicina Interna. Universidad Autónoma de Barcelona. Hospital del Mar. Barcelona.
Publications: 
Semergen 2009;35(3)122-30
Document Types: , Article
Countries: , Spain
Abstract: http://www.elsevier.es/revistas/ctl_servlet?_f=7012&articuloid=13135236&revistaid=40
Condition Year Language Analysis type
, Rheumatology 2009 Spanish , Survey research
 
 
Diseños secuenciales y análisis intermedio en la investigación clínica: tamaño frente a dificultad [Sequential designs and intermediate analysis in clinical research: size vs difficulty]
Authors: Monleón-Getino T1, Barnadas-Molins A2, Roset-Gamisans M3.
Affiliations: 1Departamento de Estadística, Universidad de Barcelona, Barcelona, España 2Servicio deOncología Médica, Hospital de Sant Pau, Barcelona, España 3IMS Health, Health Economics and Outcomes Research, Barcelona, España
Publications: 
Med Clin(Barc).2009;132(11):437–442.
Document Types: , Article
Countries: , Spain
Abstract: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B94RX-4VS9M4K-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=6d6bc4150d036492c82f145c912cb2b2
Condition Year Language Analysis type
, Clinical practice 2009 Spanish , Methodology
 
 
Coste social y asistencial de la Gastroenteritis Pediátrica por Rotavirus en España. [Cost of paediatric rotavirus gastroenteritis management in Spain].
Authors: Lara N1, Paricio Talayero JM2, Martín Sobrino MA2, Tomás Vila M3, Collar del Castillo JI3, Beseler Soto B2, Sánchez Palomares M2, Gómez Sánchez D3, y Grupo de Investigadores del estudio REVEAL en España*
Affiliations: 1IMS Health®. 2Servicio de Pediatría. Hospital «Marina Alta». Denia (Alicante). 3Servicio de Pediatría. Hospital «Francesc de Borja». Gandía (Valencia)
Publications: 
Acta Pediatr Esp. 2009;67(6):267-273.
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Pediatrics 2009 Spanish , Cost analysis
 
 
[Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol] Genotyping in patients in treatment with acenocumarol cost-effectiveness.
Authors: Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L
Affiliations: Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1Health Economics & Outcomes Research - IMS Health; 2Servicio de Hemoterapia y Hemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A
Publications: 
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics, Hematology 2009 Spanish , Cost effectiveness
 
 
Epidemiologic study to assess patients' involvement with adjuvant chemotherapy in breast cancer (PROSA study).
Authors: Tusquets I1, Espinosa Arranz E2, Méndez M3, JM Gil4, Guayar JL5, Perulero N6.
Affiliations: 1 Servicio de Oncología, Hospital de Mar, Barcelona, Spain 2 Servicio de Oncología, Hospital de la Paz, Madrid, Spain 3 Servicio de Oncología, Hospital de Móstoles, Madrid, Spain 4 Institut Català de Oncologa- hospital Duran i Reynals, L’Hospitalet, Spain 5 Sanofi-Aventis, Barcelona, Spain 6 IMS Health, HEOR Barcelona, Spain
Publications: 
Clin Transl Oncol. 2009;11(4):221-7.
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19380299
Condition Year Language Analysis type
, Oncology 2009 English , Epidemiological study
 
 
Validity of a Telephone Survey for Determining the Prevalence of Atopic Dermatitis and Its Seasonal Variation in Spain
Authors: García-Díez A1, Puig L2, Ortiz J3, Blanco A4.
Affiliations: 1 Hospital Universitario La Princesa. Madrid. España 2 Hospital de la Santa Creu i Sant Pau. Barcelona. España. 3 Hospital 12 de Octubre. Madrid. España 4 Facultad de Medicina. Valladolid. España.
Publications: 
Actas Dermosifiliogr. 2009;100(4):298-306.
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19463233
Condition Year Language Analysis type
, Dermatology 2009 English , Epidemiological study, Survey research
 
 
Patient perspectives on taking vitamin K antagonists: a qualitative study in the UK, USA and Spain
Authors: Wild D1, Murray M2, Donatti2,
Affiliations: 1 Oxford Outcomes Ltd, Oxford, UK 2 Health Protection Agency, London, UK 3 IMS Health, London, UK
Publications: 
Expert Review of Pharamacoeconomics and Outcomes Research October 2009, Vol. 9, No. 5, Pages 467-474
Document Types: , Article
Countries: , Spain, UK, USA
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Wild+D%5Bfirst+author%5D+AND+vitamin&TransSchema=title
Condition Year Language Analysis type
, Cardiovascular disease 2009 English , Observational study
 
 
Desigualdades en la financiación de medicamentos entre comunidades autónomas en España [Inequalities in the financing of medicines among autonomous regions in Spain]
Authors: Vieta A, Badia X
Affiliations: Vieta A1, Badia X1 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
Medicina Clínica (Barc). 2009;132(9):364-368
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Pricing and reimbursement 2009 Spanish
 
 
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Authors: Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J; ENIA Study Group.
Affiliations: 1 Clínico Lozano Blesa, Zaragoza, Spain 2 Vall d’Hebron, Barcelona, Spain 3 Clínic i Provincial, Barcelona, Spain 4 Xeral-Cíes, Vigo, Spain 5 Institut Català d’Oncologia, L’Hospitalet-Barcelona, Spain 6 Virgen de la Arrixaca, Murcia, Spain 7 Provincial de Castellón, Castellón, Spain 8 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 9 Amgen S.A., Barcelona, Spain
Publications: 
Curr Med Res Opin. 2009 Oct;25(10): 2533-42.
Document Types: , Article
Countries: , Spain
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990903209563
Condition Year Language Analysis type
, Hematology, Oncology 2009 English ,
 
 
Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total knee replacement in the UK and Spain
Authors: Brosa M1, Diamantopoulos A2, Forster F2, Duran A2, Lees M3, Gilmour L4, Ashley D4, Piñol C5
Affiliations: 1Oblikue Consulting, Barcelona, Spain 2 IMS Health, London, UK 3 Bayer HealthCare, Uxbridge, UK 4 Bayer plc, Newbury, UK 5 Bayer SA, Barcelona, Spain
Publications: 
14th Congress of the European Association of Hospital Pharmacists, Barcelona, Spain, 25-27 March 2009
Document Types: , Poster
Countries: , Spain, UK
Condition Year Language Analysis type
, Cardiovascular disease 2009 English , Cost effectiveness
 
 
Development and validation of a questionnaire to assess asthma control in pediatrics
Authors: Pérez-Yarza EG, Badía X, Badiola C, Cobos N, Garde J, Ibero M, Villa JR; on behalf of the CAN Investigator Group
Affiliations: Pérez-Yarza EG1, Badía X2, Badiola C3, Cobos N4, Garde J5, Ibero M6, Villa JR7; on behalf of the CAN Investigator Group81Department of Pediatrics, Division of Respiratory Medicine, Hospital Donostia, San Sebastián, Spain. 2Health Economics & Outcomes Research, IMS Health, Barcelona, Spain. 3Medical Department, GlaxoSmithKline, Tres Cantos, Madrid, Spain. 4Department of Pediatric Pneumology, Hospital Vall D’Hebron, Barcelona, Spain. 5Department of Pediatric Allergy, Hospital General, Elche, Alicante, Spain. 6Allergy Unit, Hospital de Terrassa, Terrassa, Barcelona, Spain. 7Department of Pediatric Pneumology, Hospital Niño Jesús, Madrid, Spain. 8Álvarez Gil D (Cabra), Anguita Carazo JL (Jaén), Antelo Landeira C (Madrid), Asensio De La Cruz O (Sabadell), Barrio Gómez De Agüero I (Madrid), Boné Calvo J (Zaragoza), Cortell Aznar I (Valencia), Cubero Sánchez M (Jaén), Delgado Romero J (Sevilla), Eseverri Asin JL (Barcelona), Feo Brito F (Ciudad Real), Fernández Alonso J (Palencia), Ferres Mataró J (Barcelona), García García ML (Leganés), Garde Garde J (Elche), Gómez Pastrana D (Jerez), González Y (Almería), Hernández M
Publications: 
Pediatr Pulmonol 2009;44(1):54-63.
Document Types: , Article
Countries: , Spain
Abstract: www.ncbi.nlm.nih.gov/pubmed/19061230
Condition Year Language Analysis type
, Pediatrics, Respiratory disease 2009 English , Observational study, Quality of life
 
 
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries.
Authors: Gschwend MH1, Aagren M2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Novo Nordisk Inc., New Jersey, United States
Publications: 
Journal of Medical Economics, 2009; 12(2): 114–123
Document Types: , Manuscript in preparation
Countries: , Belgium, France, Germany, Italy, Spain
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696990903080344
Condition Year Language Analysis type
, Diabetes 2009 English , Cost effectiveness
 
 
Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol. [Genotyping in patients in treatment with acenocumarol cost-effectiveness]
Authors: Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L.
Affiliations: Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1 Health Economics&Outcomes Research - IMSHealth; 2 Servicio deHemoterapia yHemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A
Publications: 
Rev Esp Econ Salud. 2009; 8(2)77-84.
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Abstract: http://www.economiadelasalud.com/ediciones/82/08_pdf/acenocumarol.pdf
Condition Year Language Analysis type
, Dermatology 2009 Spanish ,
 
 
Cost utility analysis of 90y-Ibritumomab Tiuxetan following first-line chemotherapy compared to no follow-up in patients with stage III or IV follicular lymphoma in Spain
Authors: Eggington S1, Piñol C2, Musi E3, Valderrama A4
Affiliations: 1IMS Health, London, Camden, UK, 2Bayer HealthCare, Barcelona, Spain, 3Bayer HealthCare, Sant Joan Despí (Barcelona), Catalonia, Spain, 4Bayer Healthcare Pharmaceuticals Inc, Pine Brook, NJ, USA
Publications: 
ISPOR 12th Annual European Congress, 24th – 27th October 2009, Paris, France
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2009 English , Cost utility
 
 
Estudio EPI-SCAN: Resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años de edad en España [The EPI-SCAN survey to assess the prevalence of chronic obstructive pulmonary disease in Spanish 40-to-80-year-olds: protocol summary]
Authors: Ancochea J, Badiola C, Duran-Tauleria E, Garcia Rio F, Miravitlles M, Muñoz L, Sobradillo V, Soriano JB.
Affiliations: 
Publications: 
Arch Bronconeumol. 2009;45:41-7.
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2009 Spanish , Epidemiological study, Observational study
 
 
Prevalence and dietetic management of mild gastrointestinal disorders in milk-fed infants
Authors: Infante Pina D1, Badia Llach X2, Ariño Armengol B2, Villegas Iglesias V3
Affiliations: 1 Unit of Gastroenterology and Nutrition, Children Hospital Vall d'Hebron, Autonomous University, Barcelona, Spain 2 Health Outcomes Research Europe, Barcelona, Spain 3 CHIESI España, Barcelona, Spain
Publications: 
World J Gastroenterol 2008;14(2):248-254
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2008 English , Observational study
 
 
Can the Spanish care system assume the new costs of medications against cancer?
Authors: Camps C, Caballero C, Sirera R, Blasco A, Cayuela D, Gil M, Badia X
Affiliations: 
Publications: 
Clin Transl Oncol 2008;10(2):96-101
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2008 English , Cost consequence
 
 
Nocturia in Spanish patients with lower urinary symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Authors: Hernández C1, Estivill E2, Prieto M3, Badia X4
Affiliations: 2 Institut Universitari Dexeus, Barcelona, Spain 3 Astellas Pharma, Madrid, Spain 4 IMS Health, Barcelona, Spain
Publications: 
Curr Med Res Opin 2008;24(4):1033-38
Document Types: , Article
Countries: , Spain
Abstract: http://informahealthcare.com/doi/abs/10.1185/030079908X280473
Condition Year Language Analysis type
, Urology 2008 English
 
 
Validation of the “QUICK” questionnaire. A tool for diagnosis of “wearing-off” in patients with Parkinson’s Disease
Authors: Martinez-Martín P, Tolosa E, Hernandez B, Badia X
Affiliations: 
Publications: 
Movement Disorders 2008; 23(6):830–836
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2008 English , Quality of life
 
 
Impact of skeletal complications on patients' quality of life, mobility, and functional independence
Authors: Costa L1, Badia X, Chow E3, Lipton A4, Wardley A5
Affiliations: 1 Instituto de Medicina Molecular-Lisboa, Hospital de Santa Maria, Lisbon, Portugal 2 Health Economics and Outcomes Research, Barcelona, Spain 3 Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Canada 4 Hershey Medical Center, Pennsylvania State University, Hershey, USA 5 Cancer Research Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK
Publications: 
Support Care Cancer 2008;16(8):879-89. Erratum in Supportive Care in Cancer 2008;16(10):1201
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Musculoskeletal disease 2008 English , Quality of life
 
 
Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain.
Authors: Yurgin NR1, Boye KS1, Dilla T2, Lara N3, Badia X3
Affiliations: 1Eli Lilly and Company, Indianapolis, IN, USA; 2Eli Lilly and Company, Spain; 3HEOR, IMS Health, Spain
Publications: 
Patient Preference and Adherence 2008:2 87–95.
Document Types: , Article
Countries: , Spain
Abstract: http://www.dovepress.com/physician-and-patient-management-of-type-2-diabetes-and-factors-relate-peer-reviewed-article-PPA
Condition Year Language Analysis type
, Diabetes 2008 English
 
 
Evaluation of health-related quality of life in patients with Cushing’s syndrome with a new questionnaire
Authors: Webb SM1, Badia X2, Barahona MJ3, Colao A3, Strasburger CJ4 Tabarin A5 van Aken MO5 Pivonello R3 Stalla G5 Lamberts SWJ, Glusman JE.
Affiliations: 1Department of Endocrinology, Hospital Sant Pau, Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Barcelona, Spain, 2Health Economics and Outcomes Research, IMS Health, 3Department of Endocrinology, Charite´-Universita¨tsmedizin, Berlin, Germany, 4Department of Endocrinology, Centre Hospitalier Universitaire de Bordeaux, , France, 5Department of Internal Medicine, Rotterdam, The Netherlands, 6Department of Endocrinology, Munich, Germany and 7Oncology Clinical Research, Novartis Pharmaceuticals Corporation, New Jersey, USA
Publications: 
Eur J Endocrinol 2008;158:623-30
Document Types: , Article
Countries: , Spain
Abstract: http://www.eje-online.org/cgi/content/abstract/158/5/623
Condition Year Language Analysis type
, Endocrinology 2008 English
 
 
Cuestionario especifico de calidad de vida para pacientes con estreñimiento (CVE-20): Desarrollo y validación [Specific quality of life questionnaire for patient with constipation (CVE-20): development and validation]
Authors: Perona M. Mearin F, Guilera M, Minguez M, Ortiz V, Montoso M, Serra J, Casanova CO, Rey E, Alarcón O, Bujanda L, Lima A, Andreu M, Castro M, López A, Carrillo R, Senpere L, Badia X. Grupo de estudio de los trastornos funcionales digestivos de la asociación española de gastroenterología (AEG)
Affiliations: 
Publications: 
Medicina Clínica 2008;131(10):371-377
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18842210
Condition Year Language Analysis type
, Gastrointestinal disorders 2008 Spanish , Quality of life
 
 
Evaluación de las versiones simplificadas del Cuestionario de Control del Asma [Assessment of the simplified versions of the Asthma Control Questionnaire]
Authors: Badiola C, Badia X, Sastre J, Olaguibel JM, López-Viña A, Vega JM, Picado C; en representación del grupo investigador del estudio COVALAIR
Affiliations: 
Publications: 
Med Clin 2008;131(9):326-332
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2008 Spanish , Quality of life
 
 
Economic evaluation of use of pegfilgrastim versus filgrastim in primary profilaxis in patients with breast cancer with febril neutropenia risk in Spain
Authors: Mayordomo Cámara JI, López Pousa A, Giménez García E, Badia Llach X, Lara Surinyach N, Sorio Vilela F, Liu Z, Arocho R
Affiliations: 
Publications: 
Pharmacoeconomics Spanish Research Articles 2008;5(3):71-81
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2008 Spanish , Economic evaluation
 
 
Estudio para el establecimiento de un sistema de priorización de pacientes en lista de espera para cirugía de varices [Study to establish a system for arranging patients in order of priority on a waiting list for varicose vein surgery].
Authors: Bellmunt-Montoya S, Giménez-Gaibar A, Hospedales-Salomó J, González-Cañas E, Badia X, Lara-Suriñach N
Affiliations: 
Publications: 
Angiología 2008;60(5)333-345
Document Types: , Article
Countries: , Spain
Abstract: http://biblioteca.universia.net/ficha.do?id=44765760
Condition Year Language Analysis type
, Surgery 2008 Spanish
 
 
Developing an improved measure of health outcomes: EQ-5D in transition
Authors: De Charro F1, Kind P1, Van Hout BA1, Badia X1,2
Affiliations: 1Euroqol Group, 2Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
ISPOR 13th Annual international Meeting 2008 3-7 may, Toronto, Canada
Document Types: , Workshop
Countries: , Spain
Condition Year Language Analysis type
, Miscellaneous 2008 English , Quality of life
 
 
Cost of initial prostate cancer treatment following diagnosis per patient by stage: estimates from the UK, France, Germany, Italy and Spain.
Authors: Benedict A, Black L, Stokes M, Dorval
Affiliations: 1 United BioSource Corporation, Budapest, Hungary 2 GlaxoSmithKline, Research Triangle Park, NC, USA 3 United BioSource Corporation, Dorval, QC, Canada
Publications: 
ISPOR 11th Annual European Congress
Document Types: , Abstract
Countries: , France, Germany, Italy, Spain, UK
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)66210-9/pdf
Condition Year Language Analysis type
, Oncology 2008 English , Cost effectiveness
 
 
Validation of the Spanish version of the QOLIE-10 quality of life in epilepsy questionnaire
Authors: Viteri C, Codina M, Cobaleda S, Lahuerta J, Barriga J, Barrera S, Morales MD; investigators group of the QOLIE-10 validation study
Affiliations: 
Publications: 
Neurologia 2008;23(3):157-67
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2008 Spanish , Quality of life
 
 
Development of a questionnaire on the effects of hot flashes on the quality of life of patients with advanced prostatic cancer. ESCAPA study
Authors: Carballido Rodríguez JA, Tisaire JL, Perulero N
Affiliations: 
Publications: 
Medicina Clínica 2008;130(15):561-567
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2008 Spanish , Quality of life
 
 
Quality of Life in Acromegalic Patients during long-term Somatostatin Analog Treatment with and without Pegvisomant
Authors: Neggers SJ1, van Aken MO1, de Herder WW1, Feelders RA1, Janssen JA1, Badia X2, Webb SM3, van der Lely AJ1
Affiliations: 1Department of Internal Medicine, Erasmus University MC Rotterdam, PO box 2040, 3000 CA, Rotterdam, the Netherlands. 2 Health Economics and Outcomes Research, IMS Health, Barcelona, and Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Spain. 3 Department of Endocrinology, Hospital Sant Pau, Autonomous University of Barcelona and Centre for Biomedical Research on Rare Diseases (CIBERER Unit 747), Spain.
Publications: 
Journal of Clinical Endocrinology & Metabolism 2008;93(10):3853-9
Document Types: , Online article
Countries: , Spain
Abstract: http://jcem.endojournals.org/cgi/content/abstract/93/10/3853
Condition Year Language Analysis type
, Endocrinology 2008 English , Quality of life
 
 
Cost-effectiveness analysis of darbepoetin alfa every three week versus its weekly administration in the treatment of chemotherapy-induced anemia
Authors: Riera M, Pérez F, Vieta A, Arocho R
Affiliations: 
Publications: 
Pharmacoeconomics Spanish Research Articles 2008;5(1):1-10
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2008 Spanish , Cost effectiveness
 
 
Development and Validation of \"Asthma Control in Paediatrics\" Questionnaire (CAN)
Authors: Ibero M, Badia X, Cobos N, Garde J, Pérez-Yarza E, Villa J, Badiola C
Affiliations: 
Publications: 
Journal of Allergy and Clinical Immunology 2008;119(1):S73-S73
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2008 English , Quality of life
 
 
Validation and clinical use of the CECA, a disease-specific quality of life questionnaire for patients with anogenital Condylomata Acuminata
Authors: Vilata JJ, Varela JA, Olmos L, Colombo JA, Llorens MA, de los Terreros MS, Badía X; ECCAVIM Study Group
Affiliations: 
Publications: 
Acta Derm Venereol. 2008;88(3):257-62
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2008 English , Quality of life
 
 
Using Triple Antiplatelet Therapy in Patients with Non-ST Elevation Acute Coronary Syndrome Managed Invasively: A Cost-Effectiveness Analysis
Authors: Latour-Pérez J1, de Miguel Balsa E1, Betegón L2, Badia X2
Affiliations: 1Intensive Care Unit, Hospital General Universitario de Elche, Elche, Spain; 2IMS Health Economics & Outcomes Research, Barcelona, Spain
Publications: 
Value in Health 2008;11(5)853–861
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2008 English , Cost effectiveness
 
 
Modelo de impacto presupuestario de la administración de darbepoetina alfa cada 3 semanas comparado con la administración de epoetina alfa y epoetina beta 3 veces por semana y semanalmente en pacientes con anemia inducida por quimioterapia [Budget impact model of darbepoetin alfa administered once every three weeks relative to epoetin alfa and beta administered three times per week or weekly in patients with chemotherapy induced anaemia]
Authors: Pérez-Alcántara F1, Badia Llach X1, Riera Febrer M1, Vieta Salomó A1, Arocho R2
Affiliations: 1IMSHealth®; 2Amgen S.A.
Publications: 
Revista Española de Economía de la Salud 2008; 7(1):41-48
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Cost consequence
 
 
Economic assessment of controlled-release Oxycodone for the treatment of chronic pain
Authors: Gálvez Mateos R, Camps Herrero C, Lara Suriñach N, Polanco Sánchez C
Affiliations: 
Publications: 
Rev Esp Econ Salud 2008;7(4):157-164
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Economic evaluation
 
 
Cross-cultural comparisons of the overweight/obese population in the US and Europe
Authors: Annunziata K, Gupta S, Chapnick J, Pokras S, Klingman D
Affiliations: 
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , France, Germany, Italy, Spain, UK, USA
Condition Year Language Analysis type
, Obesity 2008 English , Retrospective database analysis
 
 
Impacto sociosanitario en pacientes con enfermedades raras (estudio ERES) [Sociosanitary impact on patients with rare diseases (ERES study)]
Authors: Avellaneda Fernández A1,2, Layola M3, Izquierdo Martínez M1,4, Guilera M3, Badia Llach X3, Ramón JR1
Affiliations: 1Instituto de Investigación de Enfermedades Raras (IIER). Instituto de Salud Carlos III. Madrid. 2Centro Sanitario Los Cármenes. Comunidad de Madrid. Madrid. 3Grupo Health Outcomes Research Europe (Grupo HOR-Europe). 4Servicio de Análisis e Intervención en Salud Pública. Dirección General de Salud Pública y Alimentación. Comunidad de Madrid. Madrid. España.
Publications: 
Medicina Clinica 2007;129(17):646-51
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Market impact
 
 
The impact of insulin detemir compared to Neutral Protamine Hagedorn insulin on long-term diabetes-related complications: a modeling analysis in type 1 diabetes patients in Belgium, France, Germany, Italy and Spain
Authors: Gschwend M1, Aagren M2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland, 2 Novo Nordisk A/S, Bagsværd, Denmark
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, Spain
Condition Year Language Analysis type
, Diabetes 2008 English , Economic evaluation
 
 
Long-term cost-effectiveness of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with type 1 diabetes using a basal–bolus regimen in Belgium, France, Germany, Italy and Spain.
Authors: Gschwend M, Aagren M, Valentine WJ
Affiliations: 
Publications: 
ISPOR 2008 13th Annual International Congress
Document Types: , Poster
Countries: , Belgium, France, Germany, Italy, Spain
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Influencia del sexo en la mortalidad y el manejo del síndrome coronario agudo en España [Influence of Sex on Acute Coronary Syndrome, Mortality and Treatment in Spain].
Authors: Joaquín Alonso1, Héctor Bueno2, Alfredo Bardají3, Xavier García-Moll4, Xavier Badia5, Miquel Layola5, Ágata Carreño5
Affiliations: 1Hospital de Fuenlabrada. Fuenlabrada. Madrid. España. 2Hospital General Universitario Gregorio Marañón. Madrid. España. 3Hospital Juan XXIII. Tarragona. España. 4Hospital de la Santa Creu y Sant Pau. Barcelona. España. 5IMS Health Economics and Outcomes Research
Publications: 
Rev Esp Cardiol Supl., 2008;8:8D-22D
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2008 Spanish , Epidemiological study
 
 
Estudio del impacto económico de la gripe en el medio laboral [A study of the economic impact of influenza on the labour environment]
Authors: Badia Llach X1, Roset Gamisans M1, de Agustín de Oro T2, Álvarez Sanz C2, García Pulgar M2
Affiliations: 1 Health Economics and Outcomes Research. IMS Health. Barcelona. 2 Roche Farma, S.A. Madrid
Publications: 
Medicina del Trabajo 2008;17(1):21-29
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Immunology and Vaccination 2008 Spanish , Observational study
 
 
Assessment of Patient Satisfaction and Preferences With Inhalers in Asthma With the FSI-10 Questionnaire.
Authors: Perpiñá Tordera M1, Viejo JL2, Sanchis J3, Badia X4, Cobos N5, Picado C6, Sobradillo V7, Martínez González Del Río J8, Duce F9, Muñoz Cabrera L10
Affiliations: 1 Servicio de Neumología, Hospital Universitario La Fe, Valencia, Spain 2 Servicio de Neumología, Hospital General Yagüe, Burgos, Spain 3 Servicio de Neumología, Hospital de Sant Pau, Barcelona, Spain 4 Health Outcomes Research, Barcelona, Spain 5 Unidad de Neumología Pediátrica, Hospital Vall d’Hebron, Barcelona, Spain 6 Servicio de Neumología, Hospital Clínic, Barcelona, Spain 7 Servicio de Neumología, Hospital de Cruces, Baracaldo, Vizcaya, Spain 8 Servicio de Neumología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain 9 Servicio de Alergia, Hospital Clínico Lozano Blesa, Zaragoza, Spain 10 Servicio de Neumología, Hospital Reina Sofía, Córdoba, Spain
Publications: 
Arch Bronconeumol. 2008;44(7):346-352
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2008 English , Quality of life
 
 
Validation of the Spanish version of the Asthma Control Questionnaire (ACQ)
Authors: Picado C, Badiola C, Perulero N, Sastre J, Olaguíbel JM, López-Viña A, Vega JM
Affiliations: 
Publications: 
Clinical Therapeutics 2008;30(10)1918-1931
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2008 English , Quality of life
 
 
El impacto de la obesidad en el manejo y evolución de la diabetes mellitus [The impact of obesity in the management and evolution of diabetes mellitus.]
Authors: Dilla T1, Costi M1, Boye KS2, Reviriego J1, Yurgin N2, Badia X3, Lara-Suriñach N3
Affiliations: 1Clinical Research Department. Eli Lilly and Company. Madrid. España. 2Global Health Outcomes. Eli Lilly and Company. Corporate Center. Indianápolis. Estados Unidos. 3Health Economics and Outcomes Research (IMS Health). Barcelona. España.
Publications: 
Revista Clínica Española 2008; 208(9):437-43
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19000471
Condition Year Language Analysis type
, Diabetes 2008 Spanish , Epidemiological study
 
 
Expectativas, preferencias y satisfacción de los pacientes con artritis reumatoide en tratamiento con infliximab. [Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment]
Authors: Carbonell J1, Badia X2, EXPRESAR GROUP
Affiliations: 1Servicio de Reumatología. Hospital del Mar. Barcelona. 2Health Economics & Outcomes Research. IMS Health. Barcelona. España.
Publications: 
Med Clin (Barc) 2008;131(13):493-9.
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19007577
Condition Year Language Analysis type
, Rheumatology 2008 Spanish , Quality of life
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total knee replacement in the UK and Spain.
Authors: Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Gilmour L4, Ashley D4, Piñol C5.
Affiliations: 1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, SC, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer Healthcare Pharmaceuticals Inc, Newbury, UK, 5Bayer HealthCare, Barcelona, Spain
Publications: 
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,
Document Types: , Poster
Countries: , Spain, UK
Condition Year Language Analysis type
, Musculoskeletal disease 2008 English , Cost effectiveness
 
 
Cost-effectiveness and development of new drugs in oncology
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
2nd Symposium New Paradigms of quality of oncological assistance 2008 June 20. Valencia, Spain
Document Types: , Invited speaker
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2008 Spanish , Cost effectiveness
 
 
EuroQoL-5D: a measure in transition
Authors: Lara N1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
The 28th days on Health economics: economics, behaviour and health 2008 may 28-30, Salamanca, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Miscellaneous 2008 Spanish , Quality of life
 
 
Global and Spanish Pharmaceuticals market trends
Authors: Prior M
Affiliations: 
Publications: 
The 28th days on Health economics: economics, behaviour and health, Salamanca 28-30 may 2008
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish
 
 
Anti-TNF treatment of Crohn’s disease. Analysis between recommended posology and clinical practice
Authors: Vieta A1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
The week of digestive diseases, Sitges (Spain), 5-8 June 2008
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2008 Spanish
 
 
Retos en la evaluación económica de productos oncológicos [Challenges in economic evaluation of oncological products]
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
Summer School of pharmacoeconomics: Economic evaluation of health intervention 2008 May 18-19, Granada, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 Spanish , Economic evaluation
 
 
Cost-utility analysis in a Spanish setting of adjuvant therapy with trastuzumab (Herceptin®) in patients with her-2 positive breast cancer
Authors: Polanco C, Carulla M, Badia X, Ramirez-Arellano A
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2008 English , Cost utility
 
 
A new measure for assessing Health-Related Quality of Life (HRQOL) in patients with atrial fibrillation: AF-QOL
Authors: Arribas F Ormaetxe JM1, Peinado R2, Fernandez C, Ramírez P4, Badia X Lara N5
Affiliations: 1. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Doce de Octubre, Madrid, Spain 2. Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain 4. MEDA Pharma; Madrid, Spain 5. Health Economics and Outcomes Research, IMS Health, Barcelona, Spain
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2008 English , Quality of life
 
 
Regional market access inequalities for new oncology drugs in Spain
Authors: Vieta A1, Gimenez E1, Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2008 English
 
 
Direct medical costs of Crohn's disease in Spain: a Markov model
Authors: Casellas F1, Panés J2, Barreiro M3, Bastida G4, García V5, Guinard D6, Gomollón F7, Herrera JM8, Hinojosa J9, Marín I10, Lindner L11, Gimenez E11, Vieta A11
Affiliations: 1 Hospital Vall d’Hebron; 2 Hosp.Clínic de Barcelona; 3 Hosp. Clínico Univ.Santiago; 4 Hospital Univ. de Santiago; 5 Hosp Reina Sofía Cordoba; 6 Hospital Son Dureta; 7 Hosp. Clínico de Zaragoza; 8 Hosp Virgen del Rocío; 9 Hospital de Sagunto; 10 Hospital Gregorio Marañón Madrid; 11 HEOR IMS Health
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2008 English , Cost analysis
 
 
Using HAQ to estimate HUI3 and EQ-5D utility values in Spanish rheumatoid arthritis patients
Authors: Fernández I, Varela C, Layola M, Ruiz MD, Navarro F
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2008 English , Quality of life
 
 
Development of an instrument for assessing Health Related Quality of Life in patients with chronic urticaria
Authors: Garcia A1, Ortiz de Frutos J2, Peyrí J3, Serra E4, Rosales M5, Sabater FJ5, Badia X6
Affiliations: 1 H. de la Princesa, Madrid, Spain, 2 H.12 de Octubre, Madrid, Spain, 3 H. Bellvitge, Barcelona, Spain, 4H. de la Santa Creu I Sant Pau, Barcelona, Spain, 5 Schering Plough, Madrid, Spain, 6 IMS Health, Barcelona, Spain.
Publications: 
ISPOR 11th Annual European Congress 2008 8-11 November, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2008 English , Quality of life
 
 
Risk factors for thiazolidinedione related peripheral edema
Authors: Tennis P, Roskell N, Andrews E & Rothman K
Affiliations: RTI Health Solutions, Spain
Publications: 
Pharmacoepidemiology and Drug Safety 17(S118-S119)
Document Types: , Abstract
Countries: , Spain, UK
Condition Year Language Analysis type
, Cardiovascular disease 2008 English , Retrospective database analysis
 
 
Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.
Authors: Palmer JL1, Goodall G1, Nielsen S3, Kotchie RW,2 Valentine WJ1, Palmer AJ1, Roze S1.
Affiliations: 1IMS Health, Basel, Switzerland, 2Novo Nordisk, Bagsværd, Denmark, 3IMS Health, London, UK
Publications: 
Curr Med Res Opin. 2008; 24(5):1417-1428
Document Types: , Manuscript in preparation
Countries: , Italy, Poland, Spain, Sweden
Condition Year Language Analysis type
, Diabetes 2008 English , Cost effectiveness
 
 
Budget impact and medical resources used to control bleeds in patients hospitalized due to acute coronary syndrome (ACS)
Authors: Guijarro P, Marimón F, Guindo J, Coves FJ, Sionis A, Pedrós M, Layola M
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2007 English , Budget impact
 
 
Aplicación del análisis coste utilidad en estudios de EPOC [Applicability of cost-utility analysis in COPD studies]
Authors: Badia X
Affiliations: 
Publications: 
II Reunión del Grupo EPOC de la Sociedad Española de Medicina Interna (SEMI)[II Meeting of the COPD Spanish Internal Medicine Society Group (SEMI).] 2007 May 10-11. Valladolid, Spain
Document Types: , Conference
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2007 Spanish , Cost utility
 
 
Impacto socioeconómico de la hipercolesterolemia [Socioeconomic impact of hypercholesterolemia]
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
Cholesterol, implications of an insufficient approach: from European Union to Autonomous govenrment reality. 2007 March 22, Valencia, Spain
Document Types: , Conference
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2007 Spanish , Burden of illness
 
 
Economic evaluation of the postoperative recovery with OrthoPAT® compared to Standard therapy in knee replacement arthroplasty.
Authors: Muñoz Gómez M, Bisbe Vives E, García-Erce JA, Polanco Sánchez C, Badia Llach X.
Affiliations: 
Publications: 
PharmacoEconomics-Spanish Research Articles 2007;4(2):45-81
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Orthopedics 2007 Spanish , Economic evaluation
 
 
Treatment of chronic hepatitis C genotype 1 with Peginterferon Alfa-2a (40KD) plus Ribavirin under routine clinical practice in Spain
Authors: Diago M, Olveira A, Solá R, Romero-Gómez M, Moreno-Otero R, Pérez R et al
Affiliations: 
Publications: 
Aliment Pharmacol Ther 2007;25(8):899-906
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Infectious disease 2007 English
 
 
Impacto en el mercado de las políticas regionales de racionalización de la prescripción farmacéutica en Andalucía [Market impact of regional racionalization policies on pharmaceutical prescription in Andalucia]
Authors: Badia X1, Lara N1, Vieta A1
Affiliations:  1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
XXVII Jornadas de Economía de la Salud (AES). 2007June 6-8, La Coruña, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health policy 2007 Spanish , Market impact
 
 
From evidence-based medicine to health outcomes research:an approach to reality
Authors: Badia X, Lizán L.
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(1):42-44
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 Spanish , Methodology
 
 
The Patient Card Questionnaire to identify wearing-off in Parkinson disease
Authors: Martinez Martin P, Tolosa E, Hernandez B, Badia X
Affiliations: 
Publications: 
Clin Neuropharmacol 2007;30(5):266-75
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2007 English , Quality of life
 
 
Final development and validation of the BOMET-QoL questionnaire for assessing quality of life in patients with malignant bone disease due to neoplasia.
Authors: Sureda A, Isla D, Cózar JM, Ruiz M, Domine M, Margelí M, Adrover E, Ramos M, Pastor M, Martín A, Llombart A, Massuti B, Muñoz M, Barnadas A, Fernández J, colomer R, Allepuz C, Gilabert M, Badia X
Affiliations: 
Publications: 
J Medical Econ 2007;10:27-39
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2007 English , Quality of life
 
 
Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL)
Authors: Badia X, Arribas F, Ormaetxe JM, Peinado R, Sainz de los Terreros M.
Affiliations: IMS Health, Barcelona, Spain. xbadia@es.imshealth.com
Publications: 
Health Qual Life Outcomes 2007;5:37
Document Types: , Manuscript in preparation
Countries: , Spain
Abstract: http://www.hqlo.com/content/5/1/37/abstract
Condition Year Language Analysis type
, Cardiovascular disease 2007 English , Quality of life
 
 
Asthma Control in Spain. Do season and treatment pattern matter? ESCASE study.
Authors: Fueyo A, Ruiz MA, Ancochea J, Guilera M, Badia X on behalf of the ESCASE group.
Affiliations: 
Publications: 
Respir Med 2007;101(5): 919-924
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Methodology 2007 English
 
 
Resource use and time savings in Spain linked with new chemotherapy presentations: the case of oxaliplatin
Authors: Betegón L, Echevarria A, Soler F, Quer N
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2007 English , Burden of illness
 
 
Health Related Quality of Life of Patients with Type 2 Diabetes in Primary Care in Spain: Self-reported and Proxy Assessment using the EQ-5D.
Authors: Boye K S, Yurgin N, Dilla T, Cordero LA, Badia X, Lara Suriñach L, Perez P
Affiliations: 
Publications: 
J Med Econ 2007;10:41-58
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Quality of life
 
 
Treatment of acromegaly improves quality of life, measured by AcroQol
Authors: Paisley AN1, Rowles SV1, Roberts ME1, Webb SM2, Badia X3, Prieto L4,Shalet SM1, Trainer PJ1
Affiliations: 1 Department of Endocrinology, Christie Hospital, Wilmslow Road, Manchester, UK, 2 Hospital Sant Pau, Autonomous University of Barcelona, Padre Claret, Barcelona, 3 Health Outcomes Research Europe Group, Barcelona, Spain, 4 HealthOutcomes Consultant, Madrid, Spain
Publications: 
Clin Endocrinol (Oxf). 2007;67(3):358-62
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Endocrinology 2007 English , Quality of life
 
 
Quality of life in growth hormone deficiency and acromegaly
Authors: Webb S, Badia X
Affiliations: 
Publications: 
Endocrinol Metab Clin N Am 2007;36:221-32
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Endocrinology 2007 English , Quality of life
 
 
The effect of cancer drug vintage on cancer survival and mortality.
Authors: 
Affiliations: IMS Health
Publications: 
2007 European Society of Medical Oncology
Document Types: , Article
Countries: , France, Germany, Italy, Spain, UK
Abstract: https://academic.oup.com/annonc/article/18/suppl_3/iii67/214317/The-effect-of-cancer-drug-vintage-on-cancer
Condition Year Language Analysis type
, Oncology 2007 English
 
 
Health Related Quality of Life of Patients with Type 2 Diabetes in Primary Care in Spain: Self-reported and Proxy Assessment using the EQ-5D.
Authors: Boye K S, Yurgin N, Dilla T, Cordero LA, Badia X, Lara Suriñach L, Perez P.
Affiliations: 
Publications: 
J Med Econ 2007;10:41-58
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Quality of life
 
 
Validation of the Spanish version of the Benign Prostatic Hyperplasia Impact Index Questionnaire. “Validart study”
Authors: Carballido Rodríguez J, Grunfeld Abellán A, Escudero Callen A, Gil Bermejo FJ, Regadera-Anechina L, Badía Llach X
Affiliations: 
Publications: 
Actas Urológicas Españolas 2008;32(2):230-239
Document Types: , Article, Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Urology 2007 Spanish , Quality of life
 
 
Changes over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)
Authors: Garrigues V, Mearin F, Badia X, Balboa A, Benavent J, Caballero A, Domínguez E, Díaz-Rubio M, Roset M, Figueras M, Cucala M and RITMO Group
Affiliations: 1 Digestive Medicine Department, Hospital Universitari La Fe, Valencia, Spain 2 Institute of Functional and Motor Digestive Disorders, Centro Médico Teknon, Barcelona, Spain 3 Health Outcomes Research Europe, Barcelona, Spain 4 Centro de Atención Primaria Clinic, Barcelona, Spain 6 School of Medicine, Granada, Spain 7 Gastroenterology Department, Hospital Universitario de Santiago de Compostela, Spain; 8 Hospital Clínico de San Carlos, Madrid, Spain 9 Novartis Farmace´utica, Barcelona, Spain
Publications: 
Aliment Pharmacol Ther 2007;25(3):323-32
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17217445
Condition Year Language Analysis type
, Gastrointestinal disorders 2007 English , Observational study
 
 
Health Outcome Research and its application in ambulatory major surgery
Authors: Lara N, Badia X
Affiliations: 
Publications: 
Cirugía Mayor Ambulatoria 2007;12(4):140-7
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Surgery 2007 Spanish , Quality of life
 
 
Clinical management and economic impact of cardiovascular risk factors monitoring in obese and overweight patients in primary care
Authors: Polanco Sánchez C, Franch Nadal J, Layola Brias M, Lara Suriñach N
Affiliations: 
Publications: 
Revista Española de Economía de la Salud 2007;6(8):436-46
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Obesity 2007 Spanish , Market impact
 
 
Validation of the Spanish version of the Asthma Control Test (ACT)
Authors: Vega JM, Badia X, Badiola C, López-Viña A, Olaguíbel JM, Picado C, Sastre J, Dal-Ré R
Affiliations: 
Publications: 
Journal of Asthma 2007;44(10):867-72
Document Types: , Article
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18097865?dopt=AbstractPlus
Condition Year Language Analysis type
, Respiratory disease 2007 English , Quality of life
 
 
Timing between primary symptoms and final diagnosis of patients with memory complains and/or cognitive impairment. [Tiempo entre la aparición de los síntomas y el diagnóstico del médico de atención primaria y el especialista en los pacientes con quejas de memoria y/o deterioro cognitivo]
Authors: Argimón JM, Riu S, Badia X, Cadenas E, Martínez JM.
Affiliations: 
Publications: 
Rev Esp Geriatr Gerontol 2007;42(2):75-82
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2007 Spanish
 
 
Evaluación económica de medicamentos biotecnológicos: retos y oportunidades [Economic Evaluation of biotechnological drugs: challenge and opportunities]
Authors: Badia Llach X, Polanco Sánchez C
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(6):352-7
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 Spanish , Economic evaluation
 
 
Is the regulation of the pharmaceutical market justified?
Authors: Vieta A
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(5):278-81
Document Types: , Article
Countries: , Spain
Abstract: http://www.economiadelasalud.com/Ediciones/65/08_pdf/regulation.pdf
Condition Year Language Analysis type
, Health economics 2007 Spanish
 
 
Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream
Authors: Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA
Affiliations: 
Publications: 
British Journal of Dermatology 2007;156(4):769-771
Document Types: , Article
Countries: , Spain
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract
Condition Year Language Analysis type
, Dermatology 2007 English , Cost effectiveness
 
 
Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain
Authors: Piñola C, Roze S, Valentine W, Evers T.
Affiliations: 
Publications: 
Gaceta Sanitaria 2007;21(2):97-104
Document Types: , Manuscript in preparation
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17419924
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
A cross-sectional validation of the mini-HIV questionnaire
Authors: Pedrol E, Ortega E, Sanz J, Suárez-Lozano I, Perulero N, García Pulgar MS, Escayola R
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 English , Quality of life
 
 
Treatment cost of ulcerative colitis: Is apheresis with Adacolumn cost-effective?
Authors: Panés J, Guilera M, Ginard D, Hinojosa J, González-Carro P, González-Lara V, Varea V, Domènech E, Badia X
Affiliations: 
Publications: 
Dig Liver Dis. 2007;39(7):617-25
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2007 English , Cost effectiveness
 
 
Diagnostic management of osteoporosis patient attended in primary health care consults in Spain
Authors: Fuentes M, Ferrer J, Grifols M, Badia X, Guilera M
Affiliations: 
Publications: 
Semergen 2007;33(2):45-9
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Musculoskeletal disease 2007 Spanish
 
 
Cost-Effectiveness Analysis of Enfuvirtide (ENF) Added to an Optimized Therapy vs an Optimized Therapy Alone in Patients With HIV/AIDS.
Authors: Badia X, Lizan L, Magaz S, Alvarez C, Green J, Serrano D.
Affiliations: 
Publications: 
HIV Clinical Trials 2007;8(4):235-45
Document Types: , Manuscript in preparation
Countries: , Spain
Abstract: http://www.druglib.com/abstract/ba/badia-x_hiv-clin-trials_20070700.html
Condition Year Language Analysis type
, HIV AIDS 2007 English , Cost effectiveness
 
 
Validez de una encuesta telefónica para determinar la prevalencia y la estacionalidad de la dermatitis atópica en España [Validity of a Telephone Survey for Determining the Prevalence of Atopic Dermatitis and Its Seasonal Variation in Spain]
Authors: García A1, Puig L2, Ortiz J3, Blanco A4
Affiliations: 1 Hospital Universitario La Princesa. Madrid. España. 2 Hospital de la Santa Creu i Sant Pau. Barcelona. España. 3 Hospital 12 de Octubre. Madrid. España. 4 Facultad de Medicina. Valladolid. España.
Publications: 
Actas Dermosifiliogr. 2009;100(4):298-306.
Document Types: 
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2007 Spanish , Epidemiological study
 
 
Assessment of involved body surface area (BSA) in psoriasis patients. Validation of software assisted diagnosis BSA for the management of psoriasis
Authors: Espallardo O, Badia X, Bermudez L, Perulero N, Aragües M, Bordas X, Costa J, Dauden E, Filipe P, Ginarte M, Jimenez R, Pereiro M, Perez A, Sanchez JL, Servitje O, Vélez A
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2007 English , Epidemiological study
 
 
Comparative study of annual treatment cost of glargine insulin and detemir insulin in patients with type 2 diabetes mellitus in Spain
Authors: Alvarez de Guisasola F, Casal Llorente C, Rubio C , Betegón L
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost analysis
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in Spain.
Authors: Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Piñol C4, Febrer L4
Affiliations: 1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer HealthCare, Barcelona, Spain
Publications: 
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Hematology 2007 English , Cost effectiveness
 
 
Long-term clinical outcomes Of Insulin Detemir Versus NPH for Type I Diabetes Patients in Spain
Authors: Kotchie R1, Aagren M2, Nielsen S2, Valentine WJ3, Goodall G3
Affiliations: 1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagværd, Denmark; 3 IMS Health, Basel, Switzerland.
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Conjoint analysis a technique to develop a questionnaire of treatment preferences in patients with lung cancer
Authors: Perulero N, Cardenal F, Garcia R, Juan O, Vázquez S, Barneto I, Varela C
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2007 English , Quality of life
 
 
Evaluating the cost-effectiveness of Biphasic Insulin Aspart 30 Versus Human Premix Insulin for the Treatment of Type 2 Diabetes in a Spanish Setting
Authors: Tucker D1, Valentine WJ1, Nielsen S2, Townsend C2, Kotchie R3, Scheijbeler H3
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk, Bagsværd, Denmark; 3 IMS Health, London, UK.
Publications: 
ISPOR 2007 10th Annual European Congress, 2007 October 20-23, Dublin, Ireland
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Inequalities in the financing of drugs among autonomous regions in Spain
Authors: Badia X1, Vieta A1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Pricing and reimbursement 2007 English
 
 
A microsimulation-based cost-utility analysis of Rituximab (Mabthera®) in patients with rheumatic arthritis in Spain
Authors: Fernández I, Varela C, Badia X, Carreño Á, Polanco C
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2007 English , Cost utility
 
 
Questionnaire of treatment preferences in patients with advanced non-small cell lung cancer
Authors: Garcia R, Juan O, Vázquez S, Barneto I, Cardenal F, Varela C, Perulero N
Affiliations: 
Publications: 
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2007 English , Quality of life
 
 
Developing a disease specific CushingQoL Questionnaire
Authors: Badia X, Barahona MJ, Glusman J, Pérez P, Webb S
Affiliations: 
Publications: 
ISOQOL Conference on Patient Reported Outcomes in Clinical Practice 2007 June 24-26, , Budapest, Hungary
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Miscellaneous 2007 English , Quality of life
 
 
Factores económicos de los avances en oncología [Economic factors of advances in oncology]
Authors: Faull I1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
Congreso anual de la SEFH (Sociedad Española de Farmacia Hospitalaria)2007 Septembre 27. Tenerife, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2007 Spanish
 
 
Impacto económico y recursos empleados en el manejo del sangrado en pacientes ingresados por Síndrome Coronario Agudo [Economic impact and resources used in the management of blooding of patients treated for Acute Coronary Syndrome]
Authors: Marimón F, Guindo J, Coves FJ, Sionis A, Pedrós M, Layola M, Guijarro P
Affiliations: 
Publications: 
Congreso de la Sociedad Española de Cardiología 2007 october 18-20, Madrid, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2007 Spanish , Economic evaluation
 
 
Cost-efectivitat del tractament del malalt amb hipertensió arterial [Cost-effectiveness of treatment of patient with arterial hypertension]
Authors: Badia X1
Affiliations: 1Health Economics and Outcomes Research, IMS Health, Barcelona, Spain,
Publications: 
20 Jornades Catalanes sobre Hipertensió Arterial; 14 Reunió de la Societat Catalana d’Hipertensió Arterial 2007 December 18-19 Barcelona, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2007 Spanish , Cost effectiveness
 
 
Evaluating the long-term cost-effectiveness of insulin aspart (Novorapid®) versus human soluble insulin in patients with type 2 diabetes in Spain and Italy
Authors: Erny-Albrecht K1, Goodall G1, Townsend C2, Kotchie RW3, Nielsen S2, Valentine WJ1
Affiliations: 1 IMS Health, Basel, Switzerland; 2 Novo Nordisk, Bagsværd, Denmark; 3 IMS Health, London, UK
Publications: 
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007
Document Types: , Poster
Countries: , Italy, Spain
Condition Year Language Analysis type
, Diabetes 2007 English , Cost effectiveness
 
 
Agreement between patient and physician assessment of health-related quality life of patients with type 2 diabetes treated by primary care physicians in Spain.
Authors: Lara N, Secnik K , Yurgin N, Pérez P, Dilla T, Cordero LA, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Management and treatment adherence in type 2 diabetic patients in Spain
Authors: Secnik K, Yurgin NR, Lara N, Badia X, Dilla T, Cordero LA
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
Cost minimisation analysis of antiepileptic drugs in Spain
Authors: Rubio M, Lizán L, Badia X, Escartín A, López-Trigo J, Rufo M, Echarri E.
Affiliations: 
Publications: 
Rev Neurol 2006;42(5):257-64
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2006 Spanish , Cost minimization
 
 
Patient and physician drivers of health-related quality of life of patients with type 2 diabetes in primary care in Spain
Authors: Yurgin NR, Secnik K, Lara N, Badia X, Dilla T, Cordero LA
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English
 
 
A comparative budget impact (BI) analysis of Aranesp® (darbepoetin alfa) 500µG Q3W versus other erythropoiesis stimulating proteins (ESP) in chemotherapy-induced anemia (CIA) in Spain
Authors: Pérez Alcàntara F, Badia X, Arocho R
Affiliations: 1Health Outcomes Research, Barcelona, Barcelona, Spain, 2 Health Outcomes Research Europe, IMS Health, Barcelona, Spain, 3Amgen SA, Barcelona, Barcelona, Spain
Publications: 

ISPOR 9th Annual European Congress, 28-31 October 2006, Copenhagen, Denmark
Document Types: , Poster
Countries: , Spain
Abstract: http://www.ispor.org/congresses/denmark1006/posters2.asp#Cancer
Condition Year Language Analysis type
, Oncology 2006 English , Budget impact
 
 
The Current and Future Burden and Cost of Overactive Bladder in Five European Countries.
Authors: Reeves P1, Irwin D2, Kelleher C3, Milsom I4, Kopp Z5, Calvert N1, Lloyd A1.
Affiliations: 1 Fourth Hurdle Consulting, London, UK 2 Dept of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC,US 3 Dept of Obstetrics and Gynaecology, Guy's and St Thomas' NHS Trust, London, UK 4 Dept of Obstetrics and Gynecology, Sahlgrenska Academy at Goteborg University, Goteborg, Sweden 5 Pfizer Inc., New York, US
Publications: 
European Urology 2006; 50(5): 1050-1057
Document Types: , Manuscript in preparation
Countries: , Germany, Italy, Spain, Sweden, UK
Condition Year Language Analysis type
, Gastrointestinal disorders 2006 English , Cost of illness
 
 
Annual treatment costs of patients with rheumatoid arthritis with metotrexate and leflunomide in spain.
Authors: Rebollo P , Prieto L, Garcia A , Betegón L , Echevarria A
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2006 English , Cost of illness
 
 
Incidence and burden of illness in postoperative paralytic ileus in Spain.
Authors: Badia X, Roset M.
Affiliations: 
Publications: 
Med Clin (Barc) 2006;126(14):537-40
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2006 English , Burden of illness
 
 
Assessing quality of life of rare diseases patients in Spain. ERES STUDY.
Authors: Badia X, Layola M, Pérez P, Avellaneda A, Izquierdo M.
Affiliations: 
Publications: 
13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Validation of the patient’s attitudes and perceptions towards HAART questionnaire.
Authors: Fumaz C, Knobel H, Segador A, Lorenzo A, González J, García Pulgar M, Badia X, Perulero N.
Affiliations: 
Publications: 
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Patients and physicians perceptions towards subcutaneous treatment.
Authors: Knobel H, Fumaz CR, Segador A, Lorenzo A, González J, García Pulgar M, Perulero N.
Affiliations: 
Publications: 
8th International Congress on Drug Therapy in HIV Infection, Glasgow (UK) 12-16 November
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Study of flu costs.
Authors: Badia Llach X, Roset Gamisans M, Francés Tudel JM, Álvarez Sanz C, Rubio Terrés C.
Affiliations: 
Publications: 
Aten Primaria 2006;38(5):260-7
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2006 English , Burden of illness
 
 
Economic evaluation of treatments for non-microcytic lung cancer
Authors: Alberola V, Antón A, Carrato A, Cortés-Funes H, Guillem V, Le Lay K, et al.
Affiliations: 
Publications: 
Rev Esp Econ Salud 2007;6(4):242-9
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2006 Spanish , Economic evaluation
 
 
Use of EQ-5D questionnaire in economic evaluations
Authors: Betegón L,. Lara N, Badia X.
Affiliations: 
Publications: 
XXVII Jornadas de Economía de la Salud (AES). La Coruña 6-8 June
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 Spanish , Economic evaluation
 
 
Relationship between clinical outcomes and health related quality of life in patients with external genital warts.
Authors: Vilata JJ, Varela JA, Olmos L, Colombo JA, Llorens MA, Badia X.
Affiliations: 
Publications: 
5th Congress of the European Academy of Dermatology and Venereology-EADV, Rodhae (Greece) 4-8 October
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Infectious disease 2006 English
 
 
Prevalence of metabolic síndrome in patients with Diabetes Mellitus 2 in Spain.
Authors: Rodríguez A, Polavieja P, García R, Cobo A, Reviriego J, Carreño A.
Affiliations: 
Publications: 
XXVI Congreso de la Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC), Valencia (Spain) 15-18 November
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Diabetes 2006 English , Epidemiological study
 
 
Costs of premature death attributed to obesity in Spain.
Authors: Echevarria A, Betegón L, Badia X.
Affiliations: 
Publications: 
ISPOR 11th Annual International Meeting. Philadelphia, Pennsylvania (USA)
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Obesity 2006 English , Burden of illness
 
 
Cost analysis of febrile neutropenia management of breast cancer patients in clinical practice in Spain.
Authors: Mayordomo JI, Castellanos J, Pernas S, Ruiz-Borrego M, Velasco A, Frau A, Lamas MJ, Lara N.
Affiliations: 
Publications: 
31st European Society of Medical Oncology congress (ESMO), Estambul (Tukey) 29 Septiember-03 October
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2006 English , Burden of illness
 
 
Cost of febrile neutropenia management in cancer patients in Spain.
Authors: Mayordomo JI, Lopez A, Viñolas N, Castellanos J, Pernas S, Alonso JD, Frau A, Layola M, Gasquet JA, Sanchez JA, on behalf of the ENIA Study Group.
Affiliations: 
Publications: 
American Society of Clinical Oncology (ASCO) Annual Meeting 2006, Atlanta (GA, US) 2-6 June
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2006 English , Burden of illness
 
 
Osteoporosis in clinical daily practice.
Authors: Nogués X, Abizanda M, Carbonell C, Raber A, Balcells M, Roset M.
Affiliations: 
Publications: 
XXVI Congreso de la Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC), Valencia (Spain) 15-18 November
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Clinical practice 2006 English
 
 
Initial management of patients with subjective complaints on memory and/or cognitive impairment in Primary Care.
Authors: Argimón JM, Riu S, Lizán L, Badia X, Martínez JM.
Affiliations: 
Publications: 
ISSEA Study.
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2006 English
 
 
Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study.
Authors: Mayoral F, Montejo AL, Bousoño M, González-Torres MA, Olivares M, Ros S, et al.
Affiliations: 
Publications: 
Actas Esp Psiquiatr 2006;34(1):7-15.
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Mental health 2006 English , Quality of life
 
 
Impact of psoriasis on health-related quality of life
Authors: Ferrándiz Foraster C, García-Díez A, Lizán Tudela L, Bermúdez-Rey L, Badía Llach X
Affiliations: 
Publications: 
Med Clin 2007;128(9):325-9
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2006 Spanish , Quality of life
 
 
Quality of life: definition and concepts.
Authors: Badia X, Lizán L.
Affiliations: 
Publications: 
Martínez Martín, P. Quality of life in neurology. Barcelona: Ars Medica, 2006. p. 3-18
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Methodology 2006 English , Quality of life
 
 
Health system impact of Atopic Dermatitis in Spain in pediatric population.
Authors: García Díez A, García-Patos Briones V, Zambrano Zambrano A, Gonzalez Hachero J, Polanco Allué I, Rodrigo Gonzalo de Liria C.
Affiliations: 
Publications: 
Document Types: , In press/to be published
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2006 English
 
 
Development and validation of a satisfaction with treatment questionnaire in patients with rheumatoid artritis.
Authors: Carbonell J, Badia X and Grupo Expressar.
Affiliations: 
Publications: 
Reumatol Clin 2006;2(3):137-45
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Rheumatology 2006 English , Quality of life
 
 
Las preocupaciones en salud de las mujeres con osteoporosis: su satisfacción y adherencia con el tratamiento. [The worries in health of the women with osteoporosis: its satisfaction and adherence with the treatment]
Authors: Ferrer J, Fuentes M, Grifols M, Perulero N, Badia X.
Affiliations: 
Publications: 
Rev Esp Enferm Metab Oseas. 2006;15(1):1-7.
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Musculoskeletal disease 2006 Spanish , Quality of life
 
 
Prevalence and dietetic management dietético of slight gastrointestinal diseases in breast-fed baby: EDEN Study.
Authors: Infante D, Badia X, Ariño B, Villegas V.
Affiliations: 
Publications: 
Document Types: , In press/to be published
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2006 English
 
 
Clinical management of patients with complaints of memory decline and/or cognitive impairment in primary care in Spain.
Authors: Argimon JM, Riu S, Badia X, Lara N, Martínez J.
Affiliations: 
Publications: 
Document Types: , In press/to be published
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2006 English
 
 
Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study.
Authors: Guilera M, Fuentes M, Grifols M, Ferrer J, Badia X.
Affiliations: 
Publications: 
Osteoporos Int. 2006;17(5):664-71
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Miscellaneous 2006 English , Observational study
 
 
Economic evaluation of surgical treatment vs. Imiquimod 5% cream in patients with Superficial Basal Cell Carcinoma
Authors: Vanaclocha F, Badia X, Guillén V, Sánchez J, Sáinz de los Terreros M, Llorens MA.
Affiliations: 
Publications: 
Br J Dermatol. 2007 Apr;156(4):769-71.
Document Types: , Article
Countries: , Spain
Abstract: http://www3.interscience.wiley.com/journal/117983521/abstract?CRETRY=1&SRETRY=0
Condition Year Language Analysis type
, Health economics, Oncology 2006 English
 
 
The use of the EQ-5D in patients with osteoporosis.
Authors: Cadenas E, Perulero N, Lizán L, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Musculoskeletal disease 2006 English , Quality of life
 
 
Initial treatment of patients with subjective memory complaints and/or cognitive impairment in primary care: ISSEA Study
Authors: Argimón Pallás J, Riu Subirana S, Lizán Tudela L, Badia Llach X, Martínez Lage JM
Affiliations: 
Publications: 
Aten Prim 2007;39(4):171-9
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2006 Spanish , Epidemiological study
 
 
The Quick questionnaire identifies wearing-off in Parkinson's Disease patients. Validquick study
Authors: Martínez-Martín P, Tolosa E, Hernández B, Badia X
Affiliations: 
Publications: 
11th International Congress OF Parkinson's Disease and Movement Disorders. Istambul 3-7June
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Neurological disorders 2006 English , Quality of life
 
 
Patient reported outcomes in psoriasis
Authors: García-Díez A, Ferrandiz C, Bermudez-Rey L, Espallardo O, Lizan L, Badia X
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2006 English , Quality of life
 
 
When Direct-to-Patient health and prescription drug information is already a reality through the Internet.
Authors: Badia X, Alonso-Rodríguez Piedra N
Affiliations: 
Publications: 
Rev Esp Econ Salud 2006;5(5):272-5
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 Spanish
 
 
Clinical Practice Guideline for irritable bowel syndrome
Authors: Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J
Affiliations: 
Publications: 
Gastroenterol Hepatol. 2006;29(8):467-521
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2006 Spanish , Methodology
 
 
Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia
Authors: Carballido J, Badia X, Gimeno A, Regadera L, Dal-Ré L, Guilera M
Affiliations: 
Publications: 
Actas Urol Esp 2006;30(7):667-4
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2006 Spanish , Quality of life
 
 
Cost Minimization analysis of Bivalirudin versus Heparin plus planned abxicimab in patients undergoing Percutaneous Coronary intervention
Authors: Cequier A, Morís C, Badia X, Lara N
Affiliations: 
Publications: 
Rev Esp Econ Salud 2006;5(3):168-76
Document Types: , Article
Countries: , Spain
Condition Year Language Analysis type
, Cardiovascular disease 2006 Spanish , Cost analysis
 
 
Cost of scheduled and unscheduled asthma management in seven EU countries.
Authors: Williams AE1, Lloyd AC2, Watson L1, Rabe KF3.
Affiliations: 1 GlaxoSmithKline R&D, Greenford, 2 Fourth Hurdle Consulting Ltd, London, UK. 3 Leiden University Medical Centre, Leiden, The Netherlands
Publications: 
European Respiratory Review 2006; 15:(98): 4–9
Document Types: , Manuscript in preparation
Countries: , France, Germany, Italy, Netherlands, Spain, Sweden, UK
Condition Year Language Analysis type
, Respiratory disease 2006 English , Burden of illness
 
 
Review of the use of the EQ5D in cost-utility analysis.
Authors: Betegón L, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Review
 
 
Review of the use of the Proxy version of the EQ-5D.
Authors: Lara N, Badia X.
Affiliations: 
Publications: 
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Review
 
 
Diagnosis of allergic asthma in allergy and pneumology outpatient clinics.
Authors: Borderías L, García-Ortega P, Badia X, Casafont J, Gambús G, Roset M, y el Grupo Prevalair.
Affiliations: 
Publications: 
Gac Sanit 2006;20(6):435-41
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2006 English
 
 
Efficiency of influenza vaccination in the working population in Spain.
Authors: Juanes JR, Cisterna R, Sanz J, Magaz S, Badia X.
Affiliations: 
Publications: 
Gac Sanit 2006;20(2):101-7
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Respiratory disease 2006 English
 
 
Clinical and economic evaluation of fondaparinux vs. enoxaparin in the prophylaxis of major orthopedic surgery.
Authors: Slof J, Badia X.
Affiliations: 
Publications: 
Pharmacoeconomics-Spanish Research Articles 2006;3(2):75-88
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Surgery 2006 English
 
 
Is it efficient to inform the patient about the new drugs? An economic model for Spain.
Authors: Badia X.
Affiliations: 
Publications: 
Forum on ""New challenges for the patients"", Madrid (Spain) 25 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Socioeconomic perspective of patient information.
Authors: Badia X.
Affiliations: 
Publications: 
Health Law Congress, Madrid (Spain) 19-20 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Health outcomes research: economic evaluation of pain.
Authors: Badia X.
Affiliations: 
Publications: 
VI expert meeting on socioeconomic issues of pain. Salamanca (Spain) 25 September
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Economic evaluation in Spain: current situation.
Authors: Badia X.
Affiliations: 
Publications: 
VI Jornada de Seminarios. Health Economics (Revista Española de Economía de la Salud, IESE, Fundamed), Madrid (Spain) 26 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Health-related quality of life in Outcomes Research.
Authors: Badia X.
Affiliations: 
Publications: 
VIII Jornadas Conjuntas de las Áreas 9 y 10 de Atención Primaria. The expectations and the achievements: we measure what we do or we do what we measure?, Getafe (Spain) 11 May
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?
Authors: Koltowska-Häggström M, Mattsson A, Monson P, Kind P, Badia X, Casanueva F, Busschbach J, Koppeschaar HPF, Johannsson G.
Affiliations: 
Publications: 
Eur J Endocrinol;155:109-19
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Endocrinology 2006 English
 
 
Patient-Reported Outcomes (PRO).
Authors: Badia X.
Affiliations: 
Publications: 
XXIV Congreso de la Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Extension and implications of Health Outcomes Research(HOR).
Authors: Badia X.
Affiliations: 
Publications: 
XXIV Congreso of the Sociedad Española de Calidad Asistencial (Spanish Society of Quality in Assitance), Toledo (Spain) 24-27 October
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Premature mortality associated to obesity in Spain: Adjusted Life Years.
Authors: Betegón L, Oliva J, Echevarria A, Badia X.
Affiliations: 
Publications: 
XXVI Jornadas de Economía de la Salud (Spanish Association on Health Economy, AES), Toledo (Spain) 23-26 May
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
Direct to Patient Information on prescription drugs: economic and health impact in public health in Spain.
Authors: Badia X.
Affiliations: 
Publications: 
Press lunch organized by MSD on DTPI 2006 6 July, Madrid, Spain
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Methodology 2006 English , Review
 
 
Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Authors: Balboa A, Mearin F, Badía X, Benavent J, Caballero A, Domínguez-Muñoz JE, et al.
Affiliations: 
Publications: 
Eur J Gastroenterol Hepatol 2006;18(12):1271-7
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Gastrointestinal disorders 2006 English , Quality of life
 
 
[Documento de consenso en el uso de la granulocitoaféresis en pacientes con enfermedad inflamatoria intestinal] Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease.
Authors: Cabriada JL1, Doménech E2, Gomollón F3, González-Carro P4, González-Lara V5, Hinojosa J6, Jiménez-López CE7, Nos P8, Obrador A9, Panès J10, Saro C11, Varea V12, Lafuente R13, Guilera M14.
Affiliations: 1 Hospital de Galdakao. Galdakao. Vizcaya. España. 2 Hospital Germans Trias i Pujol. Badalona. Barcelona. España. 3 Hospital Lozano Blesa. Zaragoza. España. 4 Hospital La Mancha Centro. Alcázar de San Juan. Ciudad Real. España. 5 Hospital Gregorio Marañón. Madrid. España. 6 Hospital de Sagunto. Sagunto. Valencia. España. 7 Hospital Virgen del Camino. Pamplona. Navarra. España. 8 Hospital La Fe. Valencia. España. 9 Hospital Son Dureta. Palma de Mallorca. Baleares. España. 10 Hospital Clínic. Barcelona. España. 11 Hospital de Cabueñes. Gijón. Asturias. España. 12 Hospital Sant Joan de Déu. Esplugues de Llobregat. Barcelona. España. 13 Hospital Creu Roja. L’Hospitalet de Llobregat. Barcelona. España. 14 HOR-Europe. Barcelona. España.
Publications: 
Gastroenterol Hepatol. 2006;29(2):85-92
Document Types: , Manuscript in preparation
Countries: , Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/16448611
Condition Year Language Analysis type
, Gastrointestinal disorders 2006 Spanish , Methodology
 
 
Impact of an inspector's stamp approval policy into the atypical antipsychotic market in andalusia (Spain)
Authors: Badia X, Vieta A, Lara N, Giménez E
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: , Spain
Condition Year Language Analysis type
, Pricing and reimbursement 2006 English
 
 
Mortalidad prematura vinculada a la obesidad en España: Años Potenciales de Vida Perdidos.
Authors: Betegón L, Oliva J, Echevarria A, Badia X.
Affiliations: 
Publications: 
XXVI Jornadas de Economía de la Salud. Toledo (España)
Document Types: , Oral presentation
Countries: , Spain
Condition Year Language Analysis type
, Infectious disease 2006 Spanish
 
 
Cost effectiveness of cetuximab in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in Spain
Authors: Brosa M, Robinson P Brown B
Affiliations: Max Brosa, , Director1, Paul Robinson, BSc, MSc, Senior Economist2, Ben Brown, MSc, Economist21Oblikue Consulting, Barcelona, SC, Spain; 2 IMS Health Economics & Outcomes Research, London, United Kingdom
Publications: 

ISPOR Ninth Annual European Congress Copenhagen, Denmark October, 2006
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Oncology 2006 English , Cost effectiveness
 
 
Towards a better QALY model.
Authors: Abellán-Perpiñán J.M., Pinto-Prades J.L., Méndez-Martínez I, Badia Llach X.
Affiliations: 
Publications: 
Health Econ 2006;15:665-76
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Quality of life
 
 
When the direct to patient information in health and prescription drugs is already a fact through Internet.
Authors: Badia Llach X, Alonso-Rodríguez Piedra N.
Affiliations: 
Publications: 
Rev Esp Econ Salud 2006;5(5):272-5
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English
 
 
The new patient: the challenges of health and drugs information.
Authors: Badia X, Valentín C.
Affiliations: H.O.R. Europe, a unit of IMS
Publications: 
Madrid: MSD y Defensor del Paciente de la Comunidad de Madrid; 1st ed Merck Sharp & Dohme de España S.A, Madrid 2006;13-58
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 English , Review
 
 
Visados de inspección: ¿garantía del uso adecuado de los medicamentos o medida de control del gasto?
Authors: Gutiérrez Nicuesa L, Magaz Marqués S, Badia Llach X.
Affiliations: 
Publications: 
Aten Prim;37(5):278-86
Document Types: , Manuscript in preparation
Countries: , Spain
Condition Year Language Analysis type
, Health economics 2006 Spanish
 
 
Impact of treatment with agalsidase beta treatment on health related quality of life in patients with Fabry’s disease.
Authors: Badia X, Perez P, Layola M, Checa D, Tutor A, Torra R, Torras J, de Arriba G, García-Moncó C, Puig JM, Torregrosa V.
Affiliations: 
Publications: 
13th Annual Conference of the International Society for Quality of Life Research (ISOQOL), Lisbon (Portugal) 11-14 October
Document Types: , Poster
Countries: , Spain
Condition Year Language Analysis type
, Dermatology 2006 English
 
 
Copyright 2022 IMS Health Incorporated. All rights reserved.